<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Biomol Struct Dyn</journal-id><journal-id journal-id-type="iso-abbrev">J Biomol Struct Dyn</journal-id><journal-title-group><journal-title>Journal of Biomolecular Structure &#x00026; Dynamics</journal-title></journal-title-group><issn pub-type="ppub">0739-1102</issn><issn pub-type="epub">1538-0254</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7899166</article-id><article-id pub-id-type="pmid">33596787</article-id><article-id pub-id-type="doi">10.1080/07391102.2021.1885494</article-id><article-id pub-id-type="publisher-id">1885494</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Metabolomic profiling of three <italic>Araucaria</italic> species, and their possible potential role against COVID-19</article-title><alt-title alt-title-type="left-running-head">S. S. el-Hawary et al.</alt-title><alt-title alt-title-type="right-running-head">Journal of Biomolecular Structure and Dynamics</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>El-Hawary</surname><given-names>Seham S.</given-names></name><xref ref-type="aff" rid="AF0001">a</xref></contrib><contrib contrib-type="author"><name><surname>Rabeh</surname><given-names>Mohamed A.</given-names></name><xref ref-type="aff" rid="AF0001">a</xref><xref ref-type="aff" rid="AF0002">b</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Raey</surname><given-names>Mohamed A. El</given-names></name><xref ref-type="aff" rid="AF0003">c</xref></contrib><contrib contrib-type="author"><name><surname>El-Kadder</surname><given-names>Essam M. Abd</given-names></name><xref ref-type="aff" rid="AF0004">d</xref></contrib><contrib contrib-type="author"><name><surname>Sobeh</surname><given-names>Mansor</given-names></name><xref ref-type="aff" rid="AF0005">e</xref><xref ref-type="aff" rid="AF0006">f</xref></contrib><contrib contrib-type="author"><name><surname>Abdelmohsen</surname><given-names>Usama Ramadan</given-names></name><xref ref-type="aff" rid="AF0007">g</xref><xref ref-type="aff" rid="AF0008">h</xref><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Albohy</surname><given-names>Amgad</given-names></name><xref ref-type="aff" rid="AF0009">i</xref></contrib><contrib contrib-type="author"><name><surname>Andrianov</surname><given-names>Alexander M.</given-names></name><xref ref-type="aff" rid="AF0010">j</xref></contrib><contrib contrib-type="author"><name><surname>Bosko</surname><given-names>Ivan P.</given-names></name><xref ref-type="aff" rid="AF0011">k</xref></contrib><contrib contrib-type="author"><name><surname>Al-Sanea</surname><given-names>Mohammad M.</given-names></name><xref ref-type="aff" rid="AF0012">l</xref></contrib><contrib contrib-type="author"><name><surname>El-Kolobby</surname><given-names>Dalia G.</given-names></name><xref ref-type="aff" rid="AF0002">b</xref></contrib><aff id="AF0001"><label>a</label><institution>Department of Pharmacognosy, Faculty of Pharmacy, Cairo University</institution>, <city>Giza</city>, <country>Egypt</country></aff><aff id="AF0002"><label>b</label><institution>Department of Pharmacognosy, Faculty of Pharmacy, MTI University</institution>, <city>Cairo</city>, <country>Egypt</country></aff><aff id="AF0003"><label>c</label><institution>Department of Phytochemistry and Plant Systematics, National Research Centre</institution>, <city>Dokki</city>, <state>Cairo</state>, <country>Egypt</country></aff><aff id="AF0004"><label>d</label><institution>Timber Trees Research Department, Horticulture Research Institute, Agriculture Research Center</institution>, <city>Giza</city>, <country>Egypt</country></aff><aff id="AF0005"><label>e</label><institution>AgroBioSciences Research Division, Mohammed VI Polytechnic University</institution>, <city>Ben-Guerir</city>, <country>Egypt</country></aff><aff id="AF0006"><label>f</label><institution>Institute of Pharmacy and Molecular Biotechnology, Heidelberg University</institution>, <city>Heidelberg</city>, <country>Germany</country></aff><aff id="AF0007"><label>g</label><institution>Department of Pharmacognosy, Faculty of Pharmacy, Minia University</institution>, <city>Minya</city>, <country>Egypt</country></aff><aff id="AF0008"><label>h</label><institution>Department of Pharmacognosy, Faculty of Pharmacy, Deraya University</institution>, <city>New Minia</city>, <country>Egypt</country></aff><aff id="AF0009"><label>i</label><institution>Department of Pharmaceutical Chemistry, Faculty of Pharmacy, The British University in Egypt (BUE)</institution>, <city>Cairo</city>, <country>Egypt</country></aff><aff id="AF0010"><label>j</label><institution>Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus</institution>, <city>Minsk</city>, <country>Republic of Belarus</country></aff><aff id="AF0011"><label>k</label><institution>United Institute of Informatics Problems, National Academy of Sciences of Belarus</institution>, <city>Minsk</city>, <country>Republic of Belarus</country></aff><aff id="AF0012"><label>l</label><institution>Pharmaceutical Chemistry Department, College of Pharmacy, Jouf University</institution>, <city>Sakaka</city>, Aljouf, <country>Saudi Arabia</country></aff></contrib-group><author-notes><corresp id="AN0001"><bold>CONTACT</bold> Mohamed A. Rabeh <email>Mohamed.rabeh@pharma.cu.edu.eg</email><institution>Department of Pharmacognosy, Faculty of Pharmacy, Cairo University</institution>, <city>Giza</city>, <postal-code>11562</postal-code>, <country>Egypt</country>; Usama Ramadan Abdelmohsen <email>usama.ramadan@mu.edu.eg</email><institution>Department of Pharmacognosy, Faculty of Pharmacy, Minia University</institution>, <city>Minya</city>, <country>Egypt</country>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>2</month><year>2021</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2021</year></pub-date><fpage seq="1">1</fpage><lpage>13</lpage><permissions><copyright-statement>&#x000a9; 2021 Informa UK Limited, trading as Taylor &#x00026; Francis Group</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Informa UK Limited, trading as Taylor &#x00026; Francis Group</copyright-holder><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="TBSD_0_1885494.pdf"/><abstract><title>Abstract</title><p>The COVID-19 pandemic in Egypt is a part of the worldwide global crisis of coronavirus 2 (SARS-CoV-2). The contagious life-threatening condition causes acute respiratory syndrome. The present study aimed to assess the compounds identified by LC-MS of the methanolic leaves extracts from three conifers trees cultivated in Egypt (<italic>Araucaria bidwillii, Araucaria. cunninghamii</italic> and <italic>Araucaria heterophylla</italic>) via docking technique as potential inhibitor of COVID-19 virus on multiple targets; viral main protease (M<sup>pro</sup>, 6LU7), non-structural protein-16 which is a methyl transferase (nsp16, 6W4H) and RNA dependent RNA polymerase (nsp12, 7BV2). Among the three targets, nsp16 was the best target recognized by the tested compounds as can be deduced from docking studies. Moreover, the methanolic extract of <italic>A. cunninghamii</italic> showed the highest radical-scavenging activity using (DPPH test) with 53.7&#x02009;&#x000b5;g/mL comparable to ascorbic acid with IC<sub>50</sub> = 46&#x02009;&#x000b5;g/mL The anti-inflammatory potential carried using enzyme linked immunoassay showed the highest activity for <italic>A. cunninghamii</italic> and <italic>A. bidwillii</italic> followed by <italic>A. heterophylla</italic> with IC<sub>50</sub> = 23.20&#x02009;&#x000b1;&#x02009;1.17&#x02009;&#x000b5;g/mL, 82.83&#x02009;&#x000b1;&#x02009;3.21&#x02009;&#x000b5;g/mL and 221.13&#x02009;&#x000b1;&#x02009;6.7&#x02009;&#x000b5;g/mL, respectively (Celecoxib was used as a standard drug with IC<sub>50</sub> = 141.92&#x02009;&#x000b1;&#x02009;4.52&#x02009;&#x000b5;g/mL). Moreover, a molecular docking study was carried for the LC-MS annotated metabolites to validate their anti-inflammatory inhibitory effect using Celecoxib as a reference compound and showed a high docking score (&#x02212;7.7&#x02009;kcal/mol) for Octadecyl (<italic>E</italic>) <italic>P</italic>-coumarate and (&#x02212;7.3&#x02009;kcal/mol) for secoisolariciresinol rhamnoside.</p><p>Communicated by Ramaswamy H. Sarma</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd><italic>A. heterophylla</italic></kwd><kwd><italic>A. cunninghamii</italic></kwd><kwd><italic>A. bidwillii</italic></kwd><kwd>Araucariaceae</kwd><kwd>COVID-19</kwd><kwd>Molecular Docking</kwd><kwd>Anti-inflammatory</kwd><kwd>DPPH</kwd></kwd-group><counts><fig-count count="9"/><table-count count="9"/><page-count count="13"/><word-count count="7343"/></counts></article-meta></front><body><sec sec-type="intro" id="S0001" disp-level="1"><label>1.</label><title>Introduction</title><p>The COVID-19 pandemic in Egypt is a part of the worldwide global crisis of coronavirus 2 (SARS-CoV-2). It is a contagious condition causes acute respiratory syndrome (Chiappetta et al., <xref rid="CIT0007" ref-type="bibr">2020</xref>; Zabetakis et al., <xref rid="CIT0038" ref-type="bibr">2020</xref>). The first case reported with that disease was a women in local market in Wuhan province, China in December 2019, the scientists believe it&#x02019;s acquired from animals and started spreading between humans (<ext-link ext-link-type="uri" xlink:href="https://africacdc.org/covid-19/">https://africacdc.org/covid-19/</ext-link>). The danger of that disease is the rapid spreading as it&#x02019;s highly contagious and its vigorous symptoms which might lead to death (Schett et al., <xref rid="CIT0030" ref-type="bibr">2020</xref>). Up till now is available only a supportive treatment as a strategy in the treatment protocol, WHO welcomed the satisfactory results of using dexamethasone as a preliminary treatment for COVID-19 (World Health Organiztion, <xref rid="CIT0036" ref-type="bibr">2020</xref>) as it reduces the risk of mortality in infected patients for its role as anti-inflammatory reducing the immune-system cytokine storm reducing the exaggerated immune response caused by the COVID-19 <bold>(</bold>Mahmudpour et al., <xref rid="CIT0021" ref-type="bibr">2020</xref><bold>)</bold></p><p>Inflammation is a biological body response as a result of exposure to stimuli which provokes the immune system to eliminate the harmful stimuli. Prostaglandins are responsible for the generation of any inflammatory response (Mart&#x000ed;nez-S&#x000e1;nchez et al., <xref rid="CIT0022" ref-type="bibr">2020</xref>). Prostaglandins biosynthesis is markedly increased in inflamed tissue, arachidonic acid biosynthesis to prostaglandin H2 is catalyzed by cyclooxygenase (Lee et al., <xref rid="CIT0020" ref-type="bibr">2017</xref>). As a result of the human defense mechanism during the inflammation, there is an excessive production of reactive oxygen species by phagocytic leucocytes (Jayawardena et al., <xref rid="CIT0016" ref-type="bibr">2020</xref>), here appears the role of antioxidants to scavenge the reactive species, these auxiliary process aids tissue repair and healing (Ik et al., <xref rid="CIT0015" ref-type="bibr">2013</xref>).</p><p>Plants used medicinally considered as a huge source for constituents with biological various activities. So, it was a substantial importance to seek a plant origin drug that might provide a safer therapy to control the covid-19 symptoms or as a curative treatment. Therefore, three <italic>Araucaria</italic> species were subjected for the following study to investigate their anti-inflammatory and antioxidant potential activities. Anti-inflammatory activity for that genus was reported before using different techniques, exerting a significant results (Aslam et al., <xref rid="CIT0004" ref-type="bibr">2013</xref>; Elshamy et al., <xref rid="CIT0011" ref-type="bibr">2020</xref>) which was interesting to carry further investigations for the anti-inflammatory activity using different and accurate assay; as the enzyme immunoassay ELISA method which is performed here in the current research comparing three species.</p><p>It is well known now the role of inflammation in the pathogenesis of SARS-CoV-2 which suggests a promising effect of anti-inflammatory drugs as adjuvant therapy in COVID-19 patients to suppress the cytokine storm. Furthermore, dexamethasone was recently used to control SARS-CoV-2 progression (World Health Organiztion, <xref rid="CIT0036" ref-type="bibr">2020</xref>). This information has encouraged us to virtually investigate our compounds to see if any of them could have a potential effect on the new COVID-19 virus possible targets. The active sites of three targets, viral main protease (M<sup>pro</sup>, 6LU7), non-structural protein-16 which is a methyl transferase (nsp16, 6W4H) and RNA dependent RNA polymerase (nsp12, 7BV2) using a published recently high-resolution structure of COVID-19 main protease (Mpro ) (Jin et al., <xref rid="CIT0017" ref-type="bibr">2020</xref>; Zhang et al., <xref rid="CIT0039" ref-type="bibr">2020</xref>) allowed the chance for the creation of an inhibitor with an important role affecting the transcription and replication of virus (Aly, <xref rid="CIT0003" ref-type="bibr">2020</xref>). The importance of Mpro in the life cycle of coronavirus in contrast it is not present as an identical human homologues, introduced Mpro as favoured antiviral targeted drug designed (Pillaiyar et al., <xref rid="CIT0024" ref-type="bibr">2016</xref>).</p></sec><sec sec-type="materials" id="S0002" disp-level="1"><label>2.</label><title>Materials and methods</title><sec id="S0002-S2001" disp-level="2"><label>2.1.</label><title>Plant material</title><p><italic>A. bidwillii</italic>, <italic>A. cunninghamii</italic> and <italic>A. heterophylla</italic> leaves were collected and shed dried. The plants identity was confirmed at the Department of Flora and Phytotaxonomy, ARC, Cairo, Egypt.</p></sec><sec id="S0002-S2002" disp-level="2"><label>2.2.</label><title>Extracts preparation</title><p>The powdered leaves dried in the air of <italic>A. bidwillii</italic>, <italic>A. cunninghamii</italic> and <italic>A. heterophylla</italic> weighing 200&#x02009;g for each species, was separately extracted with methanol by percolation. methanolic extracts were subjected for evaporation under reduced pressure at 45&#x02009;&#x000b0;C to a constant weight then were subjected to lyophilization and kept in the dark at 4&#x000b0; C until analysis.</p></sec><sec id="S0002-S2003" disp-level="2"><label>2.3.</label><title>Chemical reagents</title><p>Analytical grade reagents were purchased and used with no additional purification. Organic solvents: methanol, (Adwic, Nasr Pharma, Egypt), DPPH, standardized extract of Ascorbic acid., (Memphis Co., Egypt). (2, 2-diphenyl-1-picrylhydrazyl) free radical (Sigma Co., USA), COX-1 (human) Inhibitor Screening Assay Kit., by (Caymanchem, USA), Celecoxib (Pfizer Inc., Egypt).</p></sec><sec id="S0002-S2004" disp-level="2"><label>2.4.</label><title>Metabolic profiling of A. bidwillii, A. cunninghamii and A. heterophylla</title><p>Metabolic profiling was performed on methanolic extracts of <italic>A. bidwillii</italic>, <italic>A. heterophylla</italic> and <italic>A. cunninghamii</italic> according to (Sobeh et al., <xref rid="CIT0032" ref-type="bibr">2017</xref>). HPLC-PDA-MS/MS was carried at Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Germany using a ThermoFinnigan LC system (Thermo Electron Corporation, Austin, TX, USA). A Zorbax Eclipse (XDB-C18), Rapid resolution of 4.6&#x02009;&#x000d7;&#x02009;150&#x02009;mm, 3.5&#x02009;&#x000b5;m column was used (Agilent, Santa Clara, CA, USA). Operating mass parameters were used in the negative mode. A combination of gradient water and acetonitrile (ACN), 0.1% formic acid have been used, through 60&#x02009;min in 1&#x02009;mL/min flow rate and 1:1 splitted before the ESI source, acetonitrile was raised from 5% &#x02192; 30%. The samples were injected separately using the autosampler. For MS analysis, LCQ-Duo ion trap with a ThermoQuest ESI source has been used. The Xcalibur software was used (Xcalibur&#x02122; 2.0.7, Thermo Scientific, Waltham, MA, USA) for system controlling.</p></sec><sec id="S0002-S2005" disp-level="2"><label>2.5.</label><title>Antioxidant activity evaluation by DPPH free radical scavenging assay</title><p>The plant extract ability to quench DPPH free radicals was evaluated by a standard method (Takao et al., <xref rid="CIT0033" ref-type="bibr">1994</xref>) accredited with slight modifications (Kumarasamy et al., <xref rid="CIT0019" ref-type="bibr">2007</xref>). Methanolic extracts of <italic>A. bidwillii</italic>, <italic>A. cunninghamii</italic> and <italic>A. heterophylla</italic> were dissolved in methanol to accomplish 15&#x02009;mg/mL concentrations. Dilutions were carried to have the concentrations of 500, 250, 125, 62.5, 31.25&#x02009;&#x003bc;g/mL. (100&#x02009;&#x003bc;L each) of the solutions after dilution were added to 3&#x02009;mL of methanolic solution of DPPH with the concentration of 0.002%. As, the standard ascorbic acid stock solution was dissolved in methanol for achieving a 1.5&#x02009;mg/mL concentration, dilutions were carried to achieve concentrations 50, 25, 12.5, 6.25, 3.125&#x02009;&#x003bc;g/mL incubation in the dark for 30&#x02009;min, the absorbances were observed. The reaction undergoes between the antioxidant and free radical to produce 1,1-diphenyl-2-picryl hydrazine. The capacity to quench the free radical, DPPH was recorded at the absorbance of 517&#x02009;nm.</p></sec><sec id="S0002-S2006" disp-level="2"><label>2.6.</label><title>Anti-inflammatory</title><p>The biosynthesis of AA to PGH2 is catalyzed by Cyclooxygenase. PGH2 produces PGF2&#x003b1;, via stannous chloride reduction to be assessed by enzyme immunoassay (ELISA) (Pradelles et al., <xref rid="CIT0025" ref-type="bibr">1985</xref>). This is a competitive method among a PG tracer (PG-acetylcholinesterase conjugate) and PGs for the limited quantity of PG antiserum. The PG tracer amount that can bind to the PG antiserum is indirectly proportional to the amount of PGs in the wells, the PG tracer concentration is kept constant, but PG concentration varies. This complex of antibody-PG conjugate to an antibody (anti-IgG) which was before linked to the well. The buffer and the acetylcholinesterase substrate (Ellman&#x02019;s reagent) poured to the well. The reaction enzymatically produces a yellow colour which is measured via a spectrophotometer in a Microplate special Reader (BioRad, Japan) at 412&#x02009;nm. The technique to have 100% COX activity was carried out in the presence and absence of DMSO as a solvent control. The inhibitory experiment was carried for extracts at different concentrations starting from 1 ending with 16&#x02009;&#x003bc;g total phenolic compound/mL) or of the celecoxib drug as a standard anti-inflammatory. After adding the enzyme, a pre-incubation period was allowed of 10&#x02009;min before adding the inhibitor and 2&#x02009;min of incubation in case of AA presence at 37&#x02009;&#x000b0;C. inactivation of COXs by keeping them in water and allowed to boil for 3&#x02009;min as Enzyme control. 29&#x02009;PG/mL was the detection limit and the coefficients of variations intra and interassay were 5 and 10%, respectively. The anti-inflammatory activity of the tested extracts was assessed by determining the percent of inhibition of PGE2 produced and the concentration of the test compounds leading to 50% inhibition of the release of PGE2 (IC<sub>50</sub>) was detected from the curve of concentration-inhibition response by analytical regression.</p></sec><sec id="S0002-S2007" disp-level="2"><label>2.7.</label><title>Molecular docking</title><p>Docking took place in the compounds active sites of the corresponding proteins including COX-1 (1EQG), main protease of SARS-CoV-2 (6LUV7), nsp16 (6W4H) and nsp12 (7BV2). Ligands and proteins were prepared as reported earlier (Ebada et al., <xref rid="CIT0008" ref-type="bibr">2020</xref>). In short, structures were either drawn or used from the PubChem (<ext-link ext-link-type="uri" xlink:href="http://www.pubchem.ncbi.nlm.nih.gov">www.pubchem.ncbi.nlm.nih.gov</ext-link>). Minimization for Structures via one thousand steps of steepest descent after that a minimization through one thousand steps of gradient conjugate. Available Proteins were used from the protein data bank (<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org">www.rcsb.org</ext-link>) then hydrogens were added and merged, water and non-bonded fragments were removed, and Gasteiger charges were calculated. AutoDock vina was used for carrying docking <bold>(</bold>Trott &#x00026; Olson, <xref rid="CIT0034" ref-type="bibr">2010</xref><bold>)</bold> with a grid box of 25&#x02009;&#x000d7;&#x02009;25&#x02009;&#x000d7;&#x02009;25 &#x000c5;<sup>3</sup> centered on the internal ligand using exhaustiveness of 16. PyMOL was responsible for generating images (Schrodinger, <xref rid="CIT0031" ref-type="bibr">2010</xref>).</p></sec><sec id="S0002-S2008" disp-level="2"><label>2.8.</label><title>Molecular dynamics simulation</title><p>Amber ff14SB force field was used to implement Amber18 to make the ligand-protein complexes in water. The module of antechamber was used to adjust the Gasteiger atomic partial charges (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>). For preparation of the general Amber GAFF force field and the force field parameters (Wang et al., <xref rid="CIT0035" ref-type="bibr">2004</xref>), Addition of hydrogen atoms was to target proteins via the tleap program of the AmberTools18 package (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>). First, the complexes of ligand-protein were each laid in a box with cubical shape with conditions of periodic boundary, TIP3P water as a solvent was included in the box for the MD simulations of MD. (Jorgensen et al., <xref rid="CIT0018" ref-type="bibr">1983</xref>), Cl<sup>&#x02212;</sup> and Na<sup>+</sup> ions supplied a salt of 0.10&#x02009;M concentration. the system was set up, minimization of energy was carried via five hundred steps of steepest descent algorithm and five hundred steps of gradient conjugation method. The essential atoms for complex clustering were fixed by the additional harmonic potential with constant force of 2.0&#x02009;kcal/mol subjecting the system to the phase of equilibration. Equilibration of the system was performed in three steps: (1) gradual heating of the system using a Langevin thermostat with a collision frequency of 2.0&#x02009;ps<sup>&#x02212;1</sup> heated from 0&#x02009;K to 310&#x02009;K for 1&#x02009;ns in NVT ensemble; (2) equilibration of pressure was done at 1.0&#x02009;bar in NPT for 1&#x02009;ns ensemble via Berendsen barostat with a 2.0&#x02009;ps (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>); (3) equilibration was achieved at 310&#x02009;K over 0.5&#x02009;ns in conditions of constant volume and the complex assembly constraints were eliminated. Once the equilibration was accomplished, the simulations of MD were performed at temperature <italic>T</italic>&#x02009;=&#x02009;310&#x02009;K and <italic>p</italic>&#x02009;=&#x02009;1&#x02009;bar and for 150&#x02009;ns in NPT ensemble. SHAKE algorithm was used to constrained bonds participating in hydrogen atoms (Ryckaert, <xref rid="CIT0028" ref-type="bibr">1977</xref>) for accomplishing the integration time-step of 2&#x02009;ps. Calculations of the electrostatic Long-range interactions were made via Particle Mesh Ewald algorithm (Essmann et al., <xref rid="CIT0012" ref-type="bibr">1995</xref>). Truncations at 8&#x02009;&#x000c5; of van der Waals and Coulomb interactions and the calculations of energy values of binding were made with Amber18 (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>) via the MM/GBSA method (Genheden &#x00026; Ryde, <xref rid="CIT0014" ref-type="bibr">2015</xref>). 750 snapshots were calculated produced from the final 150&#x02009;ns of the MD trajectories, by maintaining the snapshots every 0.2&#x02009;ns. Computations of the energies of the polar solvation in continuum solvent via Poisson-Boltzmann continuum-solvation model with ionic strength of 0.10. The non-polar terms were evaluated via solvent accessible surface areas. Application of the Nmode module in Amber 18 was performed for the calculation of the entropy for the binding free energy (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>). MD trajectories analysis was carried by the CPPTRAJ module of AmberTools 18 (Case et al., <xref rid="CIT0006" ref-type="bibr">2020</xref>).</p></sec></sec><sec sec-type="results" id="S0003" disp-level="1"><label>3.</label><title>Results and discussion</title><sec id="S0003-S2001" disp-level="2"><label>3.1.</label><title>A. Cunninghamii; A. bidwillii and A. heterophylla methanolic extracts metabolic profiling</title><p>Secondary metabolites of crude methanolic extract of <italic>A. bidwillii, A. cunninghamii</italic>, and <italic>A. heterophylla</italic> dereplication revealed the annotation of various compounds of different classes. The annotated compounds detect the presence of diverse phenolic acids, biflavonoids and lignans <xref rid="t0001" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="F0001">Figure 1</xref>.</p><fig id="F0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Chromatogram LC-MS of methanolic extracts of <italic>A. bidwillii</italic> (A), <italic>A. cunninghamii</italic> (B), <italic>A. heterophylla</italic> (C).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0001_C"/></fig><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Annotated compounds in the methanolic extracts of <italic>A. cunninghamii</italic>, <italic>A. bidwillii</italic> and <italic>A. heterophylla</italic>.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th rowspan="2" align="left"><bold>m/z</bold><break/><bold>(M-H)</bold></th><th rowspan="2" align="center"><bold>R.T</bold><break/><bold>(min.)</bold></th><th rowspan="2" align="center">M.wt.</th><th rowspan="2" align="center">Name</th><th rowspan="2" align="center">Molecular formula</th><th colspan="3" align="center"><italic toggle="yes">Araucaria</italic><hr/></th><th rowspan="2" align="center">References</th></tr><tr><th align="center"><italic toggle="yes">bid.</italic></th><th align="center"><italic toggle="yes">Cun.</italic></th><th align="center"><italic toggle="yes">Het.</italic></th></tr></thead><tbody valign="top"><tr><td align="left">153.10</td><td align="char" char=".">5.48</td><td align="char" char=".">154.02</td><td align="left">Protocatechuic acid</td><td align="left">C<sub>7</sub>H<sub>6</sub>O<sub>4</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Fang et al. (<xref ref-type="bibr" rid="CIT0013">2002</xref>)</td></tr><tr><td align="left">359.21</td><td align="char" char=".">5.57</td><td align="char" char=".">360.11</td><td align="left">Syringic acid glucoside</td><td align="left">C<sub>15</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Fang et al. (<xref ref-type="bibr" rid="CIT0013">2002</xref>)</td></tr><tr><td align="left">163.01</td><td align="char" char=".">7.20</td><td align="char" char=".">164.04</td><td align="left">P-Coumaric acid</td><td align="left">C<sub>9</sub>H<sub>8</sub>O<sub>3</sub></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Fang et al. (<xref ref-type="bibr" rid="CIT0013">2002</xref>)</td></tr><tr><td align="left">337.99</td><td align="char" char=".">7.22</td><td align="char" char=".">338.31</td><td align="left">P-Coumaroyl-quinic acid</td><td align="left"> C16H18O8</td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Fang et al. (<xref ref-type="bibr" rid="CIT0013">2002</xref>)</td></tr><tr><td align="left">521.26</td><td align="char" char=".">10.11</td><td align="char" char=".">522.25</td><td align="left">Secoisolariceresinol rhamnoside</td><td align="left">C<sub>27</sub>H<sub>38</sub>O<sub>10</sub></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Eklund et al. (<xref ref-type="bibr" rid="CIT0009">2008</xref>)</td></tr><tr><td align="left">167.06</td><td align="char" char=".">11.16</td><td align="char" char=".">168.04</td><td align="left">Vanillic acid</td><td align="left">C<sub>8</sub>H<sub>8</sub>O<sub>4</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Fang et al. (<xref ref-type="bibr" rid="CIT0013">2002</xref>)</td></tr><tr><td align="left">385.05</td><td align="char" char=".">15.13</td><td align="char" char=".">386.12</td><td align="left">Sinapic acid-<italic toggle="yes">O</italic>-glucoside</td><td align="left">C<sub>17</sub>H<sub>22</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">S&#x000e1;nchez&#x02010;Rabaneda et al. (<xref ref-type="bibr" rid="CIT0029">2004</xref>)</td></tr><tr><td align="left">521.00</td><td align="char" char=".">15.72</td><td align="char" char=".">522.15</td><td align="left">Lariciresinol glucoside</td><td align="left">C<sub>26</sub>H<sub>34</sub>O<sub>11</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">A&#x0011f;alar et al. (<xref ref-type="bibr" rid="CIT0002">2017</xref>)</td></tr><tr><td align="left">415.00</td><td align="char" char=".">15.91</td><td align="char" char=".">416.32</td><td align="left">Octadecyl-p-coumarate</td><td align="left">C<sub>27</sub>H<sub>44</sub>O<sub>3</sub></td><td align="left">&#x000a0;</td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Purev et al. (<xref ref-type="bibr" rid="CIT0026">1988</xref>)</td></tr><tr><td align="left">555.14</td><td align="char" char=".">21.92</td><td align="char" char=".">556.52</td><td align="left">(2S,2&#x02032;&#x02032;S)-2,3,2&#x02032;&#x02032;,3&#x02032;&#x02032;-tetrahydro-4&#x02032;- O-methyl amentoflavone</td><td align="left">C<sub>31</sub>H<sub>24</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Moawad et al. (<xref ref-type="bibr" rid="CIT0023">2010</xref>)</td></tr><tr><td align="left">523.00</td><td align="char" char=".">23.15</td><td align="char" char=".">524.13</td><td align="left">7-Hydroxy seco-isolariciresinol rhamnoside</td><td align="left">C<sub>26</sub>H<sub>36</sub>O<sub>11</sub></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Eklund et al. (<xref ref-type="bibr" rid="CIT0009">2008</xref>)</td></tr><tr><td align="left">431.24</td><td align="char" char=".">39.57</td><td align="char" char=".">432.38</td><td align="left">Apigenin 5-glucosdie</td><td align="left">C<sub>21</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Carini et al. (<xref ref-type="bibr" rid="CIT0005">2001</xref>)</td></tr><tr><td align="left">415.21</td><td align="char" char=".">41.22</td><td align="char" char=".">416.11</td><td align="left">Apigenin 5-<italic toggle="yes">O</italic>-rhamnoside</td><td align="left">C21H20O9</td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">El-Hawary et al. (<xref ref-type="bibr" rid="CIT0010">2017</xref>)</td></tr><tr><td align="left">541.23</td><td align="char" char=".">52.24</td><td align="char" char=".">542.21</td><td align="left">3&#x02032;,3&#x02032;''-binaringenin</td><td align="left">C30H22O10</td><td align="left"><bold>&#x02212;</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr><tr><td align="left">699.15</td><td align="char" char=".">52.56</td><td align="char" char=".">700.14</td><td align="left">Amentoflavone glucoside</td><td align="left">C<sub>36</sub>H<sub>28</sub>O<sub>15</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>&#x02212;</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr><tr><td align="left">713.00</td><td align="char" char=".">57.16</td><td align="char" char=".">714.10</td><td align="left">Bilobetin glucoside</td><td align="left">C<sub>31</sub>H<sub>20</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr><tr><td align="left">537.32</td><td align="char" char=".">61.05</td><td align="char" char=".">538.09</td><td align="left">Amentoflavone</td><td align="left"> &#x0200f;C<sub>30</sub>H<sub>18</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr><tr><td align="left">581.15</td><td align="char" char=".">81.29</td><td align="char" char=".">582.56</td><td align="left">2&#x02032;&#x02019;,3&#x02032;&#x02019;-dihydroheveaflavone</td><td align="left">C<sub>33</sub>H<sub>26</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr><tr><td align="left">579.19</td><td align="char" char=".">82.08</td><td align="char" char=".">580.12</td><td align="left">Kayaflavone (4&#x02032;,7&#x02032;&#x02019;,4&#x02032;&#x02019;&#x02019;-trimethyl amentoflavone</td><td align="left">C<sub>33</sub>H<sub>24</sub>O<sub>10</sub></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left"><bold>+</bold></td><td align="left">Yao et al. (<xref ref-type="bibr" rid="CIT0037">2017</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>R.T: retention time, bid: bidwillii, cun: cunninghamii, het: heterophylla.</p></fn></table-wrap-foot></table-wrap></sec><sec id="S0003-S2002" disp-level="2"><label>3.2.</label><title>Anti-inflammatory activity</title><p>The concentration inhibiting 50% of the release of PGE2 (IC<sub>50</sub>) of the extracts under investigation, <italic>A.bidwillii, A.cunninghamii</italic> and <italic>A. heterophylla</italic> to examine the extracts anti-inflammatory activity was determined from the curve of concentration-inhibition response through regression analysis. The reported values are the means of three experiments and represented in <xref rid="t0002" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="F0002">Figure 2</xref>.</p><fig id="F0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>IC<sub>50</sub> of <italic>A. cunninghamii</italic>, <italic>A. bidwillii</italic>, <italic>A. heterophylla</italic> and Celecoxib.</p></caption><graphic content-type="black-white" xlink:href="TBSD_A_1885494_F0002_B"/></fig><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>IC<sub>50</sub> of <italic>A. cunninghamii, A. bidwillii, A. heterophylla</italic> and Celecoxib.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th align="left">Methanolic extracts</th><th align="center">IC<sub>50</sub> &#x000b5;g/mL</th></tr></thead><tbody valign="top"><tr><td align="left"><italic toggle="yes">A. bidwillii</italic></td><td align="center">82.83&#x02009;&#x000b1;&#x02009;3.21</td></tr><tr><td align="left"><italic toggle="yes">A. cunninghamii</italic></td><td align="center">23.20&#x02009;&#x000b1;&#x02009;1.17</td></tr><tr><td align="left"><italic toggle="yes">A. heterophylla</italic></td><td align="center">221.13&#x02009;&#x000b1;&#x02009;6.7</td></tr><tr><td align="left">Celecoxib</td><td align="center">141.92&#x02009;&#x000b1;&#x02009;4.52</td></tr></tbody></table></table-wrap></sec><sec id="S0003-S2003" disp-level="2"><label>3.3.</label><title>Antioxidant activity</title><p>The DPPH and its % inhibition of methanolic extracts showed IC<sub>50</sub> values 93.32&#x02009;&#x003bc;g/mL, 53.7&#x02009;&#x003bc;g/mL and 120.226&#x02009;&#x003bc;g/mL for <italic>A. bidwillii</italic>, <italic>A. cunninghamii</italic> and <italic>A. heterophylla</italic> respectively. The reference drug used was ascorbic acid which showed 46&#x02009;&#x003bc;g/mL Among these results methanolic extract of <italic>A. cunninghamii</italic> exhibited a potent antioxidant activity than the other extracts followed by <italic>A. bidwillii</italic> and <italic>A. heterophylla</italic> extracts. The total results of inhibition percentage as represented in <xref rid="t0003" ref-type="table">Table 3</xref>, respective to IC<sub>50</sub> values.
<disp-formula id="M0001"><alternatives><graphic xlink:href="TBSD_A_1885494_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d2e1275"><mml:mrow><mml:mi>%</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi mathvariant="bold">Inhibition</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">
</mml:mi><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">
</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">Absorbance</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi mathvariant="bold">of</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi mathvariant="bold">sample</mml:mi><mml:mo>/</mml:mo><mml:mi mathvariant="bold">Absorbance</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi mathvariant="bold">of</mml:mi><mml:mi mathvariant="normal">
</mml:mi><mml:mi mathvariant="bold">control</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi mathvariant="normal">
</mml:mi><mml:mo>
</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mo>
</mml:mo><mml:mi mathvariant="normal">
</mml:mi><mml:mn>10</mml:mn></mml:mrow></mml:math></alternatives></disp-formula></p><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>IC<sub>50</sub> of <italic>A. cunninghamii, A. bidwillii, A. heterophylla</italic> and ascorbic acid.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th align="left">Methanolic extracts</th><th align="center">IC<sub>50</sub><break/>&#x000b5;g/mL</th></tr></thead><tbody valign="top"><tr><td align="left"><italic toggle="yes">A. bidwillii</italic></td><td align="char" char=".">93.32</td></tr><tr><td align="left"><italic toggle="yes">A. cunninghamii</italic></td><td align="char" char=".">53.7</td></tr><tr><td align="left"><italic toggle="yes">A. heterophylla</italic></td><td align="char" char=".">120.226</td></tr><tr><td align="left">Ascorbic acid</td><td align="char" char=".">46</td></tr></tbody></table></table-wrap></sec><sec id="S0003-S2004" disp-level="2"><label>3.4.</label><title>Statistical analysis</title><p>Standard Deviation (SD) &#x000b1; means data set of <italic>n</italic>&#x02009;=&#x02009;3 was determined through the subsequent equation, whilst the values of IC<sub>50</sub> were calculated from plotting inhibition percentage against concentration, via a non-linear regression algorithm. Presenting data as mean values&#x02009;&#x000b1;&#x02009;of (<italic>n</italic>&#x02009;=&#x02009;3) standard deviation.</p></sec><sec id="S0003-S2005" disp-level="2"><label>3.5.</label><title>Molecular docking</title><p>The plant extracts of <italic>A. bidwillii, A. cunninghamii, and A. heterophylla</italic> showed anti-inflammatory effects as shown by their ability to inhibit the release of PGE2. The possible inhibitory effect of compounds in the extracts for COX-1 was studied using docking. The docking study was done using 1EQG PDB file which has co-crystalized ibuprofen. To establish the docking procedure, ibuprofen was redocked in its active site and the correct pose was predicted with high accuracy (RMSD of 0.381) and the docking energy was found to be &#x02212;7.8&#x02009;kcal/mol (<xref ref-type="fig" rid="F0003">Figure 3A</xref>). This indicates the validity of docking procedure to predict correct pose. Ibuprofen (and most of the anti-inflammatory non-steroidal drugs, NSAIDS) forms 2 hydrogen bonds with R120 and Y355. The hydrophobic part of ibuprofen extends in a hydrophobic pocket formed around I345, V349, L359, I523. Selective COX-2 inhibitors, on the other hand, do not inhibit COX-1 to the same extent. Although that is the case, a selective COX-2 inhibitor, celecoxib, is known to bind to one of two subunits of COX-1 and the interference of the action of low dose aspirin (Rimon et al., <xref rid="CIT0027" ref-type="bibr">2010</xref>). Binding site of celecoxib is close but different from that of known NSAIDs such as celecoxib (<xref ref-type="fig" rid="F0003">Figure 3B</xref>). Celecoxib sulphamoyl moiety forms hydrogen bonds with S516, Q192 and L352 while hydrophobic interactions are seen with V116, L531 and V349. Redocking of celecoxib in COX-1 resulted in an energy of &#x02212;5.0&#x02009;kcal/mol.</p><fig id="F0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>A docked ibuprofen (green) in the crystal structure of COX-1 active site (1EQG) overlaid with the ibuprofen from the crystal structure (blue) with RMSD of 0.381. Key interactions are shown. B, Celecoxib binding with only one unit in the COX-1 dimer as seen in 3KK6 PDB file.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0003_C"/></fig><p>Among the tested compounds lariciresinol glucoside, octadecyl (E)-p-coumarate and p-coumaroylquinic acid showed best docking scores which is comparable or even slightly higher than that of ibuprofen (<xref rid="t0004" ref-type="table">Table 4</xref>). All the three compounds can form hydrogen bonds with the same residues similar to ibuprofen including R120 and Y355 as well as multiple hydrophobic interactions. In addition, lariciresinol glucoside and p-coumaroylquinic acid both formed hydrogen bonds with Y385 and p-coumaroylquinic acid has an extra hydrogen bond with S530 which is in close proximity to the binding pocket of celecoxib reported earlier. Proposed binding modes of these three compounds with COX-1 are illustrated in <xref ref-type="fig" rid="F0004">Figure 4</xref>.</p><fig id="F0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>Docking poses of celecoxib and top ranked compounds with COX-1 showing important hydrogen bonds and hydrophobic interactions. (A) Ibuprofen (pink), (B) lariciresinol glucoside (yellow), (C) octadecyl (E)-p-coumarate (orange) and (D) p-coumaroylquinic acid (blue).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0004_C"/></fig><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Docking score of the annotated compounds.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th rowspan="2" align="left">&#x000a0;</th><th rowspan="2" align="center">Compound</th><th rowspan="2" align="center">Cox-1 (1EQG)</th><th colspan="3" align="center">Covid-19 targets<hr/></th></tr><tr><th align="center">M<sup>pro</sup> (6LU7)</th><th align="center">nsp16 (6W4H)</th><th align="center"><bold>nsp12</bold><break/><bold>(7BV2)</bold></th></tr></thead><tbody valign="top"><tr><td align="left">1</td><td align="center">2,3,2&#x02032;',3&#x02032;'-tetrahydrobilobetin</td><td align="center">&#x02212;3.5</td><td align="center">&#x02212;9.5</td><td align="center">&#x02212;9.6</td><td align="center">&#x02212;8.9</td></tr><tr><td align="left">2</td><td align="center">2&#x02032;',3&#x02032;'-dihydroheveaflavone</td><td align="center">&#x02212;3.4</td><td align="center">&#x02212;8.0</td><td align="center">&#x02212;7.9</td><td align="center">&#x02212;8.1</td></tr><tr><td align="left">3</td><td align="center">3&#x02032;,3&#x02032;''-binaringenin</td><td align="center">&#x02212;5.8</td><td align="center">&#x02212;9.1</td><td align="center">&#x02212;9.5</td><td align="center">&#x02212;8.0</td></tr><tr><td align="left">4</td><td align="center">4&#x02032;,7,'',4&#x02032;'' tri-o-methyl amentoflavone (kayaflavone)</td><td align="center">&#x02212;3.2</td><td align="center">&#x02212;9.1</td><td align="center">&#x02212;10.1</td><td align="center">&#x02212;8.5</td></tr><tr><td align="left">5</td><td align="center">7-Hydroxy-secoisolaricersinol</td><td align="center">&#x02212;7.3</td><td align="center">&#x02212;6.6</td><td align="center">&#x02212;7.8</td><td align="center">&#x02212;5.7</td></tr><tr><td align="left">6</td><td align="center">Amentoflavone Glucoside</td><td align="center">&#x02212;6.1</td><td align="center">&#x02212;9.3</td><td align="center">&#x02212;10.0</td><td align="center">&#x02212;9.5</td></tr><tr><td align="left">7</td><td align="center">Amentoflavone</td><td align="center">&#x02212;3.7</td><td align="center">&#x02212;9.8</td><td align="center">&#x02212;10.1</td><td align="center">&#x02212;8.5</td></tr><tr><td align="left">8</td><td align="center">Apigenin 5-<italic toggle="yes">O</italic>-rhamnoside</td><td align="center">&#x02212;6.5</td><td align="center">&#x02212;8.3</td><td align="center">&#x02212;8.8</td><td align="center">&#x02212;6.9</td></tr><tr><td align="left">9</td><td align="center">Apigenin 5-glucoside</td><td align="center">&#x02212;6.7</td><td align="center">&#x02212;8.4</td><td align="center">&#x02212;8.8</td><td align="center">&#x02212;7.4</td></tr><tr><td align="left">10</td><td align="center">Bilobetin glucoside</td><td align="center">&#x02212;6.3</td><td align="center">&#x02212;9.7</td><td align="center">&#x02212;10.1</td><td align="center">&#x02212;9.0</td></tr><tr><td align="left">11</td><td align="center">Lariciresinol glucoside</td><td align="center">&#x02212;8.0</td><td align="center">&#x02212;7.7</td><td align="center">&#x02212;9.0</td><td align="center">&#x02212;7.6</td></tr><tr><td align="left">12</td><td align="center">Octadecyl (E)-p-coumarate</td><td align="center">&#x02212;7.7</td><td align="center">&#x02212;4.9</td><td align="center">&#x02212;6.2</td><td align="center">&#x02212;4.5</td></tr><tr><td align="left">13</td><td align="center">p-coumaric acid</td><td align="center">&#x02212;6.3</td><td align="center">&#x02212;5.1</td><td align="center">&#x02212;6.0</td><td align="center">&#x02212;5.2</td></tr><tr><td align="left">14</td><td align="center">p-coumaroylquinic acid</td><td align="center">&#x02212;7.5</td><td align="center">&#x02212;7.1</td><td align="center">&#x02212;7.8</td><td align="center">&#x02212;6.8</td></tr><tr><td align="left">15</td><td align="center">Protocatechuic acid</td><td align="center">&#x02212;6.1</td><td align="center">&#x02212;5.4</td><td align="center">&#x02212;6.5</td><td align="center">&#x02212;5.7</td></tr><tr><td align="left">16</td><td align="center">Secoisolariciresinol rhamnoside</td><td align="center">&#x02212;7.3</td><td align="center">&#x02212;7.1</td><td align="center">&#x02212;8.5</td><td align="center">&#x02212;5.9</td></tr><tr><td align="left">17</td><td align="center">Sinapic acid-O-glucoside</td><td align="center">&#x02212;6.3</td><td align="center">&#x02212;6.9</td><td align="center">&#x02212;7.6</td><td align="center">&#x02212;6.7</td></tr><tr><td align="left">18</td><td align="center">Syringic acid glucoside</td><td align="center">&#x02212;5.8</td><td align="center">&#x02212;7.4</td><td align="center">&#x02212;6.4</td><td align="center">&#x02212;5.8</td></tr><tr><td align="left">19</td><td align="center">Vanillic acid</td><td align="center">&#x02212;6.0</td><td align="center">&#x02212;5.1</td><td align="center">&#x02212;6.3</td><td align="center">&#x02212;5.5</td></tr><tr><td align="left">&#x000a0;</td><td align="center">Co-crystalized Ligand</td><td align="center">&#x02212;<bold>7.8 (ibuprofen)</bold></td><td align="center">&#x02212;<bold>7.9</bold><break/><bold>(N3)</bold></td><td align="center">&#x02212;<bold>8.2 (SAM)</bold></td><td align="center">&#x02212;<bold>6.6 (Remdesivir)</bold></td></tr></tbody></table></table-wrap><p>A recent study has shown that the anti-inflammatory corticosteroid dexamethasone has positive effect in improving survival rate of COVID-19 hospitalized patients as demonstrated by randomized clinical trials (Abdolahi et al., <xref rid="CIT0001" ref-type="bibr">2020</xref>). This suggests promising effect of anti-inflammatory drugs as adjuvant therapy in COVID-19 patients for challenging the storm of cytokine which is a state of release of excessive of a diverse of inflammatory cytokines. The molecular mechanism of the cytokine storm is still unexplored. We were encouraged to theoretically study possible effect of our identified compounds against multiple targets of SARS-CoV-2. The compounds identified were docked in 3 targets active sites, viral main protease (M<sup>pro</sup>, 6LU7), non-structural protein-16 which is a methyl transferase (nsp16, 6W4H) and RNA dependent RNA polymerase (nsp12, 7BV2). <xref rid="t0004" ref-type="table">Table 4</xref> shows the docking results of tested compounds against the 3 viral targets. In general, bioflavonoids have shown better scores compared to other compounds in all the three targets. Among the three targets, nsp16 was the best target recognized by the tested compounds as can be deduced from docking energies of each compound with the 3 targets (<xref rid="t0004" ref-type="table">Table 4</xref>). Three biflavonoids were among the top compounds bound to nsp16 with energies better than S-adenosylmethionine (SAM) which is the co-crystalized ligand. These biflavonoids include kayaflavone, amentoflavone and Bilobetin glucoside. A representative example of the binding of kayaflavone and amentoflavone is shown in <xref ref-type="fig" rid="F0005">Figure 5</xref>. Rings A and B of biflavonoids overlapped with the purine ring of the SAM and form similar hydrogen bonds with D6912 and C6913. Other hydrogen bonds are also formed with D6897. The other side of the bioflavonoids extends into the KDKE methyl transferase motif and forms hydrogen bonds with E7001 in case of kayaflavone and with K6968 for amentoflavone. These results suggest possible effect of these compounds against SARS-CoV-2 and worth further investigation.</p><fig id="F0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Binding mode and interactions of kayaflavone (top, pink) and amentoflavone (bottom, yellow) in the active site of nsp16. Compounds are overlapped with SAM (blue).</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0005_C"/></fig><fig id="F0006" orientation="portrait" position="float"><label>Figure 6.</label><caption><p>The time dependences calculated of the RMSD (&#x000c5;) between all of the MD ligand/COX-1 structures and their starting models. The backbone atoms of COX-1 were used in the calculations. The graphs shown correspond to the following ligand/COX-1 complexes: (a) A/COX-1, (b) B/COX-1, (c) C/COX-1, and (D) IBP/COX-1.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0006_C"/></fig></sec><sec id="S0003-S2006" disp-level="2"><label>3.6.</label><title>Molecular dynamics simulations</title><p>So, the molecular docking data revealed that all selected compounds effectively block the target proteins and that is confirmed by the binding energy values lower compared with those predicted for the molecules used as a positive control in the calculations. However, it is well-known that estimating the binding affinity profiles using molecular docking studies involves a number of approximations, resulting in the Lack of trustworthiness on the capability of scoring functions to produce accurate values of binding free energy (Meng et al., <xref rid="CIT0040" ref-type="bibr">2011</xref>; Salmaso &#x00026; Moro, <xref rid="CIT0041" ref-type="bibr">2018</xref>). In this context, the parameters of thermodynamic depending on the MD simulations are much more credible than those predicted from the analysis of the static docking models. contrary of the computational approaches, MD simulation moves each atom individually through the field of the rested atoms showing the flexibility of both the ligand and protein which is more effective than other algorithms (Meng et al., <xref rid="CIT0040" ref-type="bibr">2011</xref>; Salmaso &#x00026; Moro, <xref rid="CIT0041" ref-type="bibr">2018</xref>).</p><p>Nevertheless, analyzed compounds to the target proteins resulted from the post-modeling analysis of the static ligand/protein structures their data, is confirmed by the MD simulations the high binding affinity. Analysis of the dynamic ligand/protein models shows that, in both cases of interest, within the MD simulations, these complexes are relatively stable, as proved by the averages of binding free energies and the corresponding standard deviations (<xref rid="t0005" ref-type="table">Table 5</xref>). With the Given MM/GBSA method errors of 1&#x02013;3&#x02009;kcal/mol (Genheden &#x00026; Ryde, <xref rid="CIT0014" ref-type="bibr">2015</xref>), we can propose that the dynamic ligand/protein structures having the averages of binding free energy lower than those calculated for the reference compounds using the same computational protocols (<xref rid="t0005" ref-type="table">Table 5</xref>). The exception is compound B' targeting the NSP16-10 protein of SARS-Cov-2 and exhibiting the binding affinity comparable with that obtained for the control molecule SAM (<xref rid="t0005" ref-type="table">Table 5</xref>).</p><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Values mean of binding free energy&#x02009;&#x0003c;&#x02009;&#x00394;G&#x02009;&#x0003e;&#x02009;for the compounds analyzed and their standard deviations (&#x00394;G)<sub>STD.</sub></p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">COX-1<hr/></th></tr><tr><th align="left">Compound</th><th align="center">&#x0003c;&#x00394;H&#x0003e;&#x02009;&#x000b1; (&#x00394;H)<sub>STD</sub><break/>(kcal/mol)</th><th align="center">&#x0003c;T&#x00394;S&#x0003e;&#x02009;&#x000b1;(T&#x00394;S)<sub>STD</sub> (kcal/mol)</th><th align="center">&#x0003c;&#x00394;G&#x0003e;&#x02009;&#x000b1; (&#x00394;G)<sub>STD</sub> (kcal/mol)</th></tr></thead><tbody valign="top"><tr><td align="left">A</td><td align="center">&#x02212;64.39&#x02009;&#x000b1;&#x02009;3.39</td><td align="center">&#x02212;24.69&#x02009;&#x000b1;&#x02009;10.76</td><td align="center">&#x02212;39.71&#x02009;&#x000b1;&#x02009;11.74</td></tr><tr><td align="left">B</td><td align="center">&#x02212;54.04&#x02009;&#x000b1;&#x02009;3.69</td><td align="center">&#x02212;24.15&#x02009;&#x000b1;&#x02009;10.09</td><td align="center">&#x02212;29.90&#x02009;&#x000b1;&#x02009;10.97</td></tr><tr><td align="left">C</td><td align="center">&#x02212;50.41&#x02009;&#x000b1;&#x02009;4.50</td><td align="center">&#x02212;18.92&#x02009;&#x000b1;&#x02009;6.05</td><td align="center">&#x02212;31.49&#x02009;&#x000b1;&#x02009;7.28</td></tr><tr><td align="left">IBP</td><td align="center">&#x02212;33.20&#x02009;&#x000b1;&#x02009;2.07</td><td align="center">&#x02212;15.24&#x02009;&#x000b1;&#x02009;8.26</td><td align="center">&#x02212;17.95&#x02009;&#x000b1;&#x02009;8.72</td></tr><tr><td colspan="4"><bold>NSP16-10</bold></td></tr><tr><td align="left">A'</td><td align="center">&#x02212;38.93&#x02009;&#x000b1;&#x02009;4.02</td><td align="center">&#x02212;23.60&#x02009;&#x000b1;&#x02009;5.42</td><td align="center">&#x02212;15.33&#x02009;&#x000b1;&#x02009;6.44</td></tr><tr><td align="left">B'</td><td align="center">&#x02212;27.84&#x02009;&#x000b1;&#x02009;7.01</td><td align="center">&#x02212;19.21&#x02009;&#x000b1;&#x02009;3.29</td><td align="center">&#x02212;8.63&#x02009;&#x000b1;&#x02009;7.10</td></tr><tr><td align="left">C'</td><td align="center">&#x02212;44.14&#x02009;&#x000b1;&#x02009;3.26</td><td align="center">&#x02212;24.69&#x02009;&#x000b1;&#x02009;5.97</td><td align="center">&#x02212;19.45&#x02009;&#x000b1;&#x02009;5.84</td></tr><tr><td align="left">SAM</td><td align="center">&#x02212;27.30&#x02009;&#x000b1;&#x02009;4.69</td><td align="center">&#x02212;18.60&#x02009;&#x000b1;&#x02009;7.19</td><td align="center">&#x02212;8.70&#x02009;&#x000b1;&#x02009;8.51</td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>The compounds are designated as follows: <italic>A</italic>&#x02014;3-Lariciresinol-glucoside, <italic>B</italic>&#x02014;14-Octadecyl (E)-p-coumarate, <italic>C</italic>&#x02014;16-p-coumaroylquinic acid, IBP&#x02014;Ibuprofen. A'&#x02014;5-Kayaflavon, B'&#x02014;8-Amentoflavone, C'&#x02014;11-Bilobetin-glucoside, SAM&#x02014;S-Adenosylmethionine.</p></fn><fn id="TF3"><p>Values of mean of enthalpic and entropic components of free energy are &#x0003c;&#x00394;H&#x02009;&#x0003e;&#x02009;and&#x02009;&#x0003c;&#x02009;T&#x00394;S&#x0003e;, respectively; standard deviations corresponding to these values are (&#x00394;H)<sub>STD</sub> and (T&#x00394;S)<sub>STD</sub></p></fn></table-wrap-foot></table-wrap><p>Regarding the observed stability of the dynamic ligand/protein structures is also an evidence for the data depending on the time of the root-mean square deviations (RMSD) for the atomic positions of the static and dynamic models of the analyzed compounds bounding to the target proteins (<xref ref-type="fig" rid="F0006">Figures 6</xref> and <xref ref-type="fig" rid="F0007">7</xref>). Analysis of <xref ref-type="fig" rid="F0006">Figures 6</xref> and <xref ref-type="fig" rid="F0007">7</xref> reveals that these complexes do not support significant structural rearrangements on the MD trajectories, and this is confirmed by the calculated RMSD averages of the dynamic models of molecules A, B, C and A, B, C in the complexes with COX-1 and NSP16-10, respectively. For the ligand/COX-1 complexes, the RMSD mean values and standard deviations, which are 2.48&#x02009;&#x000b1;&#x02009;0.58&#x02009;&#x000c5; (compound A), 2.74&#x02009;&#x000b1;&#x02009;0.35&#x02009;&#x000c5; (compound B), 2.64&#x02009;&#x000b1;&#x02009;0.37 (compound C), are close to those of 2.34&#x02009;&#x000b1;&#x02009;0.36&#x02009;&#x000c5; calculated for the COX-1 inhibitor IBP (<xref ref-type="fig" rid="F0006">Figure 6</xref>). In the case of the ligand/NSP16-10 complexes, these averages are 2.94&#x02009;&#x000b1;&#x02009;0.74&#x02009;&#x000c5; (compound A'), 2.90&#x02009;&#x000b1;&#x02009;0.33&#x02009;&#x000c5; (compound B'), 2.55&#x02009;&#x000b1;&#x02009;0.26&#x02009;&#x000c5; (compound C'), and 3.31&#x02009;&#x000b1;&#x02009;0.37&#x02009;&#x000c5; (SAM).</p><fig id="F0007" orientation="portrait" position="float"><label>Figure 7.</label><caption><p>The time dependences of the RMSD (&#x000c5;) calculated between all of the MD ligand/NSP16-10 structures and their starting models. The backbone atoms of NSP16-10 were used in the calculations. The graphs shown correspond to the following ligand/COX-1 complexes: (a) A'/NSP16-10, (b) B'/ NSP16-10, (c) C'/ NSP16-10, and (D) SAM/ NSP16-10.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0007_C"/></fig><fig id="F0008" orientation="portrait" position="float"><label>Figure 8.</label><caption><p>Values of RMSF (&#x000c5;) for each residue along the COX-1 amino-acid sequence. Numbering of the protein amino acids corresponds to an original PDB numbering in the following manner: 1-551&#x02009;&#x02212;&#x02009;33-583.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0008_C"/></fig><p>Comparison of the MD structures between every subsequent dynamic model with the previous one results in the averages of RMSD which are also evidence of the relative stability of the ligand/protein complexes at MD simulations. For the compounds bound to COX-1, these averages equal to 0.77&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x000c5; (compound A), 0.78&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x000c5; (compound B) and 0.78&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x000c5; (compound C) are very close to those calculated for the control molecule IBP (0.76&#x02009;&#x000b1;&#x02009;0.05&#x02009;&#x000c5;). Compounds A', B', C' show the mean values of RMSD in the complexes with NSP16-10 which are respectively 0.84&#x02009;&#x000b1;&#x02009;0.06&#x02009;&#x000c5;, 0.84&#x02009;&#x000b1;&#x02009;0.06&#x02009;&#x000c5;, 0.83&#x02009;&#x000b1;&#x02009;0.06&#x02009;&#x000c5; and very close to the SAM/NSP16-10 structure (0.85&#x02009;&#x000b1;&#x02009;0.06&#x02009;&#x000c5;).</p><p>Enthalpy components decomposition of the binding energy to the contributions of individual COX-1 amino acids exposes the residues dominating the ligand/COX-1 interactions in all cases of interest (<xref rid="t0006" ref-type="table">Table 6</xref>). Analysis of <xref rid="t0006" ref-type="table">Table 6</xref> shows that these COX-1 residues are Val-116, Val-349, Leu-352, Tyr-355, Ile-523, and Ala-527. The data obtained suggest that there are a number of the basic anchoring residues of COX-1 that provide strong attachment of the analyzed compounds at the active site of this protein. This supposition is supported by the values of the data of root-mean-square fluctuations (RMSF) for residues of COX-1 designating the flexibility of each amino acid throughout the MD simulations (<xref ref-type="fig" rid="F0008">Figure 8</xref>, <xref rid="t0007" ref-type="table">Table 7</xref>). Analysis of <xref rid="t0007" ref-type="table">Table 7</xref> shows that, according to the values of RMSF, the key anchoring residues Val-116, Val-349, Leu-352, Tyr-355, Ile-523, and Ala-527 of COX-1 their position are restrained on the MD trajectories, in agreement with the data on their contributions into the binding enthalpy (<xref rid="t0006" ref-type="table">Table 6</xref>).</p><fig id="F0009" orientation="portrait" position="float"><label>Figure 9.</label><caption><p>Values of RMSF (&#x000c5;) for each residue along the NSP16-10 amino-acid sequence. Numbering of the protein amino acids along the X-axis corresponds to an original PDB numbering in the following manner: 1-299&#x02009;&#x02212;&#x02009;6798-7096 and 300-415&#x02009;&#x02212;&#x02009;4271-4386.</p></caption><graphic content-type="color" xlink:href="TBSD_A_1885494_F0009_C"/></fig><table-wrap id="t0006" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Averages of the binding enthalpy for the amino-acid residues of COX-1 bound to compounds A, B and C<sup>a,2,3</sup>.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">Compound<hr/></th></tr><tr><th align="left">Residue of COX-1</th><th align="center">A</th><th align="center">B</th><th align="center">C</th></tr></thead><tbody valign="top"><tr><td colspan="4"><bold>Residue Contribution to the Binding Enthalpy (kcal/mol)</bold></td></tr><tr><td align="left">ILE-89</td><td align="center">&#x02212;1.17&#x02009;&#x000b1;&#x02009;0.50</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-93</td><td align="center">&#x02212;0.90&#x02009;&#x000b1;&#x02009;0.51</td><td align="center">&#x02212;0.85&#x02009;&#x000b1;&#x02009;0.37</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-112</td><td align="center">&#x02212;0.59&#x02009;&#x000b1;&#x02009;0.48</td><td align="center">&#x02212;1.02&#x02009;&#x000b1;&#x02009;0.42</td><td align="center">&#x02013;</td></tr><tr><td align="left">MET-113</td><td align="center">&#x02013;</td><td align="center">&#x02212;1.52&#x02009;&#x000b1;&#x02009;0.74</td><td align="center">&#x02013;</td></tr><tr><td align="left"><bold>VAL-116</bold></td><td align="center">&#x02212;<bold>1.44&#x02009;&#x000b1;&#x02009;0.35</bold></td><td align="center">&#x02212;<bold>1.52&#x02009;&#x000b1;&#x02009;0.40</bold></td><td align="center">&#x02212;<bold>0.74&#x02009;&#x000b1;&#x02009;0.31</bold></td></tr><tr><td align="left">LEU-117</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.80&#x02009;&#x000b1;&#x02009;0.47</td><td align="center">&#x02212;0.69&#x02009;&#x000b1;&#x02009;0.32</td></tr><tr><td align="left">ARG-120</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.54&#x02009;&#x000b1;&#x02009;0.36</td></tr><tr><td align="left">ILE-345</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.60&#x02009;&#x000b1;&#x02009;0.50</td></tr><tr><td align="left"><bold>VAL-349</bold></td><td align="center">&#x02212;<bold>1.90&#x02009;&#x000b1;&#x02009;0.31</bold></td><td align="center">&#x02212;<bold>1.32&#x02009;&#x000b1;&#x02009;0.34</bold></td><td align="center">&#x02212;<bold>1.67&#x02009;&#x000b1;&#x02009;0.34</bold></td></tr><tr><td align="left"><bold>LEU-352</bold></td><td align="center">&#x02212;<bold>1.86&#x02009;&#x000b1;&#x02009;0.39</bold></td><td align="center">&#x02212;<bold>1.22&#x02009;&#x000b1;&#x02009;0.36</bold></td><td align="center">&#x02212;<bold>1.48&#x02009;&#x000b1;&#x02009;0.33</bold></td></tr><tr><td align="left">SER-353</td><td align="center">&#x02212;0.88&#x02009;&#x000b1;&#x02009;0.33</td><td align="center">&#x02212;0.70&#x02009;&#x000b1;&#x02009;0.25</td><td align="center">&#x02212;0.76&#x02009;&#x000b1;&#x02009;0.28</td></tr><tr><td align="left"><bold>TYR-355</bold></td><td align="center">&#x02212;<bold>1.59&#x02009;&#x000b1;&#x02009;0.68</bold></td><td align="center">&#x02212;<bold>1.15&#x02009;&#x000b1;&#x02009;0.38</bold></td><td align="center">&#x02212;<bold>0.72&#x02009;&#x000b1;&#x02009;0.31</bold></td></tr><tr><td align="left">LEU-357</td><td align="center">&#x02212;0.70&#x02009;&#x000b1;&#x02009;0.52</td><td align="center">&#x02212;1.09&#x02009;&#x000b1;&#x02009;0.45</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-359</td><td align="center">&#x02212;0.48&#x02009;&#x000b1;&#x02009;0.24</td><td align="center">&#x02212;1.39&#x02009;&#x000b1;&#x02009;0.53</td><td align="center">&#x02212;0.94&#x02009;&#x000b1;&#x02009;0.27</td></tr><tr><td align="left">LEU-384</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.57&#x02009;&#x000b1;&#x02009;0.28</td></tr><tr><td align="left">TRP-387</td><td align="center">&#x02212;0.47&#x02009;&#x000b1;&#x02009;0.24</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">PHE-518</td><td align="center">&#x02212;0.93&#x02009;&#x000b1;&#x02009;0.26</td><td align="center">&#x02212;0.52&#x02009;&#x000b1;&#x02009;0.26</td><td align="center">&#x02212;0.87&#x02009;&#x000b1;&#x02009;0.28</td></tr><tr><td align="left">MET-522</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.56&#x02009;&#x000b1;&#x02009;0.33</td></tr><tr><td align="left"><bold>ILE-523</bold></td><td align="center">&#x02212;<bold>2.26&#x02009;&#x000b1;&#x02009;0.64</bold></td><td align="center">&#x02212;<bold>1.16&#x02009;&#x000b1;&#x02009;0.35</bold></td><td align="center">&#x02212;<bold>1.59&#x02009;&#x000b1;&#x02009;0.47</bold></td></tr><tr><td align="left">GLY-526</td><td align="center">&#x02212;0.83&#x02009;&#x000b1;&#x02009;0.26</td><td align="center">&#x02212;0.50&#x02009;&#x000b1;&#x02009;0.24</td><td align="center">&#x02212;0.89&#x02009;&#x000b1;&#x02009;0.24</td></tr><tr><td align="left"><bold>ALA-527</bold></td><td align="center">&#x02212;<bold>1.90&#x02009;&#x000b1;&#x02009;0.33</bold></td><td align="center">&#x02212;<bold>1.34&#x02009;&#x000b1;&#x02009;0.31</bold></td><td align="center">&#x02212;<bold>1.63&#x02009;&#x000b1;&#x02009;0.31</bold></td></tr><tr><td align="left">SER-530</td><td align="center">&#x02212;0.46&#x02009;&#x000b1;&#x02009;0.38</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.47&#x02009;&#x000b1;&#x02009;0.41</td></tr><tr><td align="left">LEU-531</td><td align="center">&#x02212;0.61&#x02009;&#x000b1;&#x02009;0.27</td><td align="center">&#x02212;0.56&#x02009;&#x000b1;&#x02009;0.27</td><td align="center">&#x02212;1.51&#x02009;&#x000b1;&#x02009;0.55</td></tr></tbody></table><table-wrap-foot><fn id="TF4"><p><sup>a</sup>Data for the COX-1 residues with the binding enthalpy &#x02264;&#x02009;&#x02212;0.4&#x02009;kcal/mol are presented.</p></fn><fn id="TF5"><p><sup>b</sup>The averages of the residue contributions to the binding enthalpy and corresponding standard deviations are given.</p></fn><fn id="TF6"><p><sup>c</sup>The COX-1 residues dominating the ligand/protein interaction are highlighted by bold.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t0007" orientation="portrait" position="float"><label>Table 7.</label><caption><p>Values of RMSF for the COX-1 residues contributing to the binding enthalpy.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">Compound<hr/></th></tr><tr><th align="left">Residue of COX-1</th><th align="center">A</th><th align="center">B</th><th align="center">C</th></tr></thead><tbody valign="top"><tr><td colspan="4"><bold>Values of RMSF (&#x000c5;) for the individual residues of COX-1</bold></td></tr><tr><td align="left">ILE-89</td><td align="center">3.47</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-93</td><td align="center">3.07</td><td align="center">1.19</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-112</td><td align="center">1.23</td><td align="center">1.46</td><td align="center">&#x02013;</td></tr><tr><td align="left">MET-113</td><td align="center">&#x02013;</td><td align="center">1.35</td><td align="center">&#x02013;</td></tr><tr><td align="left"><bold>VAL-116</bold></td><td align="center"><bold>1.53</bold></td><td align="center"><bold>1.47</bold></td><td align="center"><bold>1.22</bold></td></tr><tr><td align="left">LEU-117</td><td align="center">&#x02013;</td><td align="center">1.32</td><td align="center">1.34</td></tr><tr><td align="left">ARG-120</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">1.44</td></tr><tr><td align="left">ILE-345</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">0.70</td></tr><tr><td align="left"><bold>VAL-349</bold></td><td align="center"><bold>0.62</bold></td><td align="center"><bold>0.75</bold></td><td align="center"><bold>0.69</bold></td></tr><tr><td align="left"><bold>LEU-352</bold></td><td align="center"><bold>0.73</bold></td><td align="center"><bold>0.80</bold></td><td align="center"><bold>0.97</bold></td></tr><tr><td align="left">SER-353</td><td align="center">0.77</td><td align="center">0.89</td><td align="center">1.06</td></tr><tr><td align="left"><bold>TYR-</bold>355</td><td align="center"><bold>1.08</bold></td><td align="center"><bold>1.08</bold></td><td align="center"><bold>1.29</bold></td></tr><tr><td align="left">LEU-357</td><td align="center">0.91</td><td align="center">1.06</td><td align="center">&#x02013;</td></tr><tr><td align="left">LEU-359</td><td align="center">0.82</td><td align="center">0.99</td><td align="center">0.88</td></tr><tr><td align="left">LEU-384</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">0.63</td></tr><tr><td align="left">TRP-387</td><td align="center">0.63</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">PHE-518</td><td align="center">0.87</td><td align="center">0.73</td><td align="center">0.97</td></tr><tr><td align="left">MET-522</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">0.73</td></tr><tr><td align="left"><bold>ILE-</bold>523</td><td align="center"><bold>0.80</bold></td><td align="center"><bold>1.19</bold></td><td align="center"><bold>0.71</bold></td></tr><tr><td align="left">GLY-526</td><td align="center">0.80</td><td align="center">0.91</td><td align="center">0.78</td></tr></tbody></table><table-wrap-foot><fn id="TF7"><p>The COX-1 residues presenting the dominant contributors to the ligand/protein interaction are highlighted by bold.</p></fn></table-wrap-foot></table-wrap><p>The data on decomposition of binding energy into the contributions of individual NSP16-10 amino acids are given in <xref rid="t0008" ref-type="table">Table 8</xref>, and the data on the values of RMSF for the individual residues of this protein are presented in <xref ref-type="fig" rid="F0009">Figure 9</xref> and <xref rid="t0009" ref-type="table">Table 9</xref>.</p><table-wrap id="t0008" orientation="portrait" position="float"><label>Table 8.</label><caption><p>Averages of the binding enthalpy for the amino-acid residues of NSP16-10 bound to compounds A', B' and C'<sup>a,b,c</sup>.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">Compound<hr/></th></tr><tr><th align="left">Residue of NSP16-10</th><th align="center">A'</th><th align="center">B'</th><th align="center">C'</th></tr></thead><tbody valign="top"><tr><td colspan="4"><bold>Residue Contribution to the Binding Enthalpy (kcal/mol)</bold></td></tr><tr><td align="left">GLY-6869</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.55&#x02009;&#x000b1;&#x02009;0.24</td></tr><tr><td align="left"><bold>LEU-6898</bold></td><td align="center">&#x02212;<bold>3.91&#x02009;&#x000b1;&#x02009;0.89</bold></td><td align="center">&#x02212;<bold>0.98&#x02009;&#x000b1;&#x02009;1.14</bold></td><td align="center">&#x02212;<bold>2.10&#x02009;&#x000b1;&#x02009;0.80</bold></td></tr><tr><td align="left">ASN-6899</td><td align="center">&#x02212;1.06&#x02009;&#x000b1;&#x02009;0.80</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">CYS-6913</td><td align="center">&#x02212;0.64&#x02009;&#x000b1;&#x02009;0.35</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.56&#x02009;&#x000b1;&#x02009;0.36</td></tr><tr><td align="left"><bold>MET-6929</bold></td><td align="center">&#x02212;<bold>1.97&#x02009;&#x000b1;&#x02009;0.40</bold></td><td align="center">&#x02212;<bold>0.65&#x02009;&#x000b1;&#x02009;0.91</bold></td><td align="center">&#x02212;<bold>2.08&#x02009;&#x000b1;&#x02009;0.47</bold></td></tr><tr><td align="left"><bold>TYR-6930</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">&#x02212;<bold>2.39&#x02009;&#x000b1;&#x02009;0.94</bold></td><td align="center">&#x02212;<bold>1.54&#x02009;&#x000b1;&#x02009;0.59</bold></td></tr><tr><td align="left">ASP-6931</td><td align="center">&#x02212;0.60&#x02009;&#x000b1;&#x02009;0.53</td><td align="center">&#x02013;</td><td align="center">&#x02212;1.05&#x02009;&#x000b1;&#x02009;0.51</td></tr><tr><td align="left"><bold>PRO-6932</bold></td><td align="center">&#x02212;<bold>1.51&#x02009;&#x000b1;&#x02009;0.87</bold></td><td align="center">&#x02212;<bold>2.54&#x02009;&#x000b1;&#x02009;0.74</bold></td><td align="center">&#x02212;<bold>1.08&#x02009;&#x000b1;&#x02009;0.78</bold></td></tr><tr><td align="left">LYS-6933</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.54&#x02009;&#x000b1;&#x02009;0.83</td><td align="center">&#x02013;</td></tr><tr><td align="left">THR-6934</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.73&#x02009;&#x000b1;&#x02009;0.44</td></tr><tr><td align="left">LYS-6935</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.76&#x02009;&#x000b1;&#x02009;1.03</td><td align="center">&#x02013;</td></tr><tr><td align="left">LYS-6944</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.63&#x02009;&#x000b1;&#x02009;0.25</td></tr><tr><td align="left"><bold>PHE-6947</bold></td><td align="center">&#x02212;<bold>1.59&#x02009;&#x000b1;&#x02009;0.89</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">&#x02212;<bold>2.01&#x02009;&#x000b1;&#x02009;0.61</bold></td></tr><tr><td align="left">PHE-6948</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td><td align="center">&#x02212;0.79&#x02009;&#x000b1;&#x02009;0.27</td></tr><tr><td align="left">LEU-7093</td><td align="center">&#x02212;0.71&#x02009;&#x000b1;&#x02009;0.91</td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr></tbody></table><table-wrap-foot><fn id="TF8"><p><sup>a</sup>Data for the NSP16-10 residues with the binding enthalpy &#x02264;&#x02009;&#x02212;0.4&#x02009;kcal/mol are presented.</p></fn><fn id="TF9"><p><sup>b</sup>The averages of the residue contributions to the binding enthalpy and corresponding standard deviations are given.</p></fn><fn id="TF10"><p><sup>c</sup>The NSP16-10 residues dominating the ligand/protein interaction are highlighted by bold.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t0009" orientation="portrait" position="float"><label>Table 9.</label><caption><p>RMSF values for the NSP16-10 residues in contribution to the binding enthalpy.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">Compound<hr/></th></tr><tr><th align="left">Residue of NSP16-10</th><th align="center">A'</th><th align="center">B'</th><th align="center">C'</th></tr></thead><tbody valign="top"><tr><td colspan="4"><bold>RMSF values (&#x000c5;) for the individual residues of NSP16-10</bold></td></tr><tr><td align="left">GLY-6869</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">0.65</td></tr><tr><td align="left"><bold>LEU-6898</bold></td><td align="center"><bold>0.90</bold></td><td align="center"><bold>0.87</bold></td><td align="center"><bold>0.97</bold></td></tr><tr><td align="left">ASN-6899</td><td align="center">1.12</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td></tr><tr><td align="left">CYS-6913</td><td align="center">1.74</td><td align="center"><bold>&#x02013;</bold></td><td align="center">1.23</td></tr><tr><td align="left"><bold>MET-6929</bold></td><td align="center"><bold>0.63</bold></td><td align="center"><bold>0.67</bold></td><td align="center"><bold>0.79</bold></td></tr><tr><td align="left"><bold>TYR-6930</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>0.80</bold></td><td align="center"><bold>0.94</bold></td></tr><tr><td align="left">ASP-6931</td><td align="center">1.29</td><td align="center"><bold>&#x02013;</bold></td><td align="center">1.16</td></tr><tr><td align="left"><bold>PRO-6932</bold></td><td align="center"><bold>1.70</bold></td><td align="center"><bold>1.07</bold></td><td align="center"><bold>1.24</bold></td></tr><tr><td align="left">LYS-6933</td><td align="center"><bold>&#x02013;</bold></td><td align="center">1.06</td><td align="center"><bold>&#x02013;</bold></td></tr><tr><td align="left">THR-6934</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">1.32</td></tr><tr><td align="left">LYS-6935</td><td align="center"><bold>&#x02013;</bold></td><td align="center">0.90</td><td align="center"><bold>&#x02013;</bold></td></tr><tr><td align="left">LYS-6944</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">0.68</td></tr><tr><td align="left"><bold>PHE-6947</bold></td><td align="center"><bold>0.91</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>0.70</bold></td></tr><tr><td align="left">PHE-6948</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td><td align="center">0.63</td></tr><tr><td align="left">LEU-7093</td><td align="center">3.12</td><td align="center"><bold>&#x02013;</bold></td><td align="center"><bold>&#x02013;</bold></td></tr></tbody></table><table-wrap-foot><fn id="TF11"><p>The NSP16-10 residues presenting the dominant contributors to the ligand/protein interaction are highlighted by bold.</p></fn></table-wrap-foot></table-wrap><p>Intermolecular calculations of hydrogen bonds appeared in the MD trajectories of the ligand/COX-1 complexes indicate (<xref rid="t0010" ref-type="table">Table 10</xref>) that the concerned compounds form hydrogen bonds with Arg-120<sub>COX-1</sub> (compound A), Leu-117<sub>COX-1</sub> (compound B), Ala-527<sub>COX-1</sub> and Leu-531<sub>COX-1</sub> (compound C). Notably, as compound C, the control molecule IBP is also involved in hydrogen bonding with Leu-531<sub>COX-1</sub> (<xref rid="t0010" ref-type="table">Table 10</xref>). Analysis of the dynamic ligand/NSP16-10 models reveals hydrogen bonds between compound A' and Asn-6899<sub>NSP16-10</sub>, compound B' and Lys-6933<sub>NSP16-10</sub>, as well as compound C' and Lys-6930<sub>NSP16-10</sub>, Asp-6931<sub>NSP16-10</sub>, Met-6929 <sub>NSP16-10</sub>, and Cys-6913 <sub>NSP16-10</sub>. At the same time, the reference compound SAM forms hydrogen bonds with the NSP16-10 residues Thr-4292, Asn-4293, Val-4295 (<xref rid="t0010" ref-type="table">Table 10</xref>). Among these H-bonds, it should be specially noted hydrogen bonds C&#x000b7;&#x000b7;&#x000b7;Ala-527<sub>COX-1</sub> and C'&#x000b7;&#x000b7;&#x000b7;Lys-6930<sub>NSP16-10</sub> demonstrating the relatively high percentage occupancies on the MD trajectories (<xref rid="t0010" ref-type="table">Table 10</xref>).</p><table-wrap id="t0010" orientation="portrait" position="float"><label>Table 10.</label><caption><p>Intermolecular hydrogen bonds in the dynamic ligand/protein structures.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="4" align="left">Hydrogen Bonds</th></tr></thead><tbody valign="top"><tr><td align="left"><bold>Ligand</bold></td><td align="left"><bold>COX-1</bold></td><td align="center"><bold>Ligand</bold></td><td align="left"><bold>NSP16-10</bold></td></tr><tr><td align="left">A</td><td align="left">O&#x02026;HN[Arg-120; 10.83%]</td><td align="center">A'</td><td align="left">O&#x02026;HN[Asn-6899; 29.48%]</td></tr><tr><td align="left">B</td><td align="left">O&#x02026;HN[Leu-117; 28.08%]</td><td align="center">B'</td><td align="left">O&#x02026;HN[Lys-6933; 12.43%]</td></tr><tr><td align="left">C</td><td align="left">O&#x02026;HN[Ala-527; 68.37%] O&#x02026;HN[Leu-531; 18.63%]</td><td align="center">C'</td><td align="left">O&#x02026;HN[Lys-6930; 59.96%], O&#x02026;HN[Asp-6931; 45.91%], O&#x02026;HN[Met-6929; 25.15%] O&#x02026;HN[Cys-6913; 17.69%]</td></tr><tr><td align="left">IBP</td><td align="left">O&#x02026;HN[Leu-531; 10.19%]</td><td align="center">SAM</td><td align="left">NH<sub>2</sub>&#x02026;O[Thr-4292; 17.16%], NH<sub>1</sub>&#x02026;O[Thr-4292; 17.16%], NH<sub>2</sub>&#x02026;O[Asn-4293; 12.65%], NH<sub>1</sub>&#x02026;O[Asn-4293; 12.65%], O&#x02026;HN[Val-4295; 11.03%]</td></tr></tbody></table><table-wrap-foot><fn id="TF12"><p>Donors and acceptors of the hydrogen bonds relating to the ligands are shown first, followed by the corresponding functional groups of the protein amino acids. The protein residues and percentage occupancies of hydrogen bonds are indicated in square brackets.</p></fn><fn id="TF13"><p>The data on the hydrogen bonds exhibiting percentage occupancies &#x0003e;10%are given.</p></fn></table-wrap-foot></table-wrap><p>Thus, the data of molecular modeling indicate that the analyzed compounds show strong attachment to the target proteins. This follows from the calculation of low binding free energy values for the ligand/protein complexes in terms of the scoring functions of molecular docking and molecular dynamics. In both cases, the predicted values of this thermodynamic parameter testify to the higher binding affinity of the identified compounds to their targets compared with the reference molecules IBP and SAM.</p></sec></sec><sec sec-type="conclusions" id="S0004" disp-level="1"><label>4.</label><title>Conclusions</title><p>In light of the results of the current investigation, we propose that the extracts of <italic>A. bidwillii, A. cunninghamii</italic> and <italic>A. heterophylla</italic> cultivated in Egypt, could be a possible source of potent natural anti-inflammatory and antioxidant metabolites. Those activities are of extensive importance as medicated agents for inhibiting and regress the progression of inflammation correlated with oxidative stress-relevant to viral infection and trying to avoid the side effects accompanied by the administration of dexamethasone such as elevated blood pressure, oedema and hyperglycemia. Those results were deduced from the virtual study carried for the structure relationship of LC-MS annotated compounds and the receptor interactions in three different binding sites of proteolytic enzyme in the COVID-19 as all the tested exhibited significant binding stability as observed for the amentoflavone and bilobetin glucoside with significant low binding energy. Our data suggested possible effect of these compounds against SARS-CoV-2 and worth further investigation. Several pathological conditions for instance as processes of inflammation are accompanied with reactive oxygen species generation. Thus, inhibitory activity on COX-1 enzyme of these plant extracts probably due to their capacity to reduce oxidative stress. Finally, we believe that the potential anti-COVID effects of the reported compounds required and worth further investigations.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to extend their sincere appreciation to the central laboratory at Jouf University for support this study. M.M. Al-Sanea also extends his appreciation to the Korea Institute of Science and Technology (KIST) for funding this work through the Grant name &#x0201c;2021 KIST School Partnership Project&#x0201d;.</p></ack><sec id="S0005" disp-level="1" sec-type="COI-statement"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abdolahi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Kaheh</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Golsha</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Khodabakhshi</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Norouzi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Khandashpoor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Besharat</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tavassoli</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Livani</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Azimi</surname>, <given-names>S. A.</given-names></string-name>, <string-name><surname>Gharib</surname>, <given-names>M. H.</given-names></string-name>, <string-name><surname>Peivandi</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Fazel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shirzad-Aski</surname>, <given-names>H.</given-names></string-name>, &#x00026; <string-name><surname>Roshandel</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Letter to the editor: Efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: A structured summary of a study protocol for a randomized controlled trial</article-title>. <source><italic toggle="yes">Trials</italic></source>, <volume><italic toggle="yes">21</italic></volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1186/s13063-020-04499-5</pub-id><pub-id pub-id-type="pmid">31898511</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>A&#x0011f;alar</surname>, <given-names>H. G.</given-names></string-name>, <string-name><surname>&#x000c7;ift&#x000e7;i</surname>, <given-names>G. A.</given-names></string-name>, <string-name><surname>G&#x000f6;ger</surname>, <given-names>F.</given-names></string-name>, &#x00026; <string-name><surname>K&#x00131;r&#x00131;mer</surname>, <given-names>N.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Activity guided fractionation of Arum italicum miller tubers and the LC/MS-MS profiles</article-title>. <source><italic toggle="yes">Records of Natural Products</italic></source>, <volume><italic toggle="yes">12</italic></volume>(<issue>1</issue>), <fpage>64</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.25135/rnp.06.17.05.089</pub-id></mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Aly</surname>, <given-names>O. M.</given-names></string-name></person-group> (<year>2020</year>). Molecular docking reveals the potential of aliskiren, dipyridamole, mopidamol, rosuvastatin, rolitetracycline and metamizole to inhibit COVID-19 virus main protease.</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aslam</surname>, <given-names>M. S.</given-names></string-name>, <string-name><surname>Choudhary</surname>, <given-names>B. A.</given-names></string-name>, <string-name><surname>Uzair</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Ijaz</surname>, <given-names>A. S.</given-names></string-name></person-group> (<year>2013</year>). <article-title>Phytochemical and ethno-pharmacological review of the genus Araucaria&#x02013;review</article-title>. <source><italic toggle="yes">Tropical Journal of Pharmaceutical Research</italic></source>, <volume><italic toggle="yes">12</italic></volume>(<issue>4</issue>), <fpage>651</fpage>&#x02013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.4314/tjpr.v12i4.31</pub-id></mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carini</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Aldini</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Furlanetto</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Stefani</surname>, <given-names>R.</given-names></string-name>, &#x00026; <string-name><surname>Facino</surname>, <given-names>R. M.</given-names></string-name></person-group> (<year>2001</year>). <article-title>LC coupled to ion-trap MS for the rapid screening and detection of polyphenol antioxidants from Helichrysum stoechas</article-title>. <source><italic toggle="yes">Journal of Pharmaceutical and Biomedical Analysis</italic></source>, <volume><italic toggle="yes">24</italic></volume>(<issue>3</issue>), <fpage>517</fpage>&#x02013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1016/S0731-7085(00)00431-3</pub-id><pub-id pub-id-type="pmid">11199231</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Case</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Belfon</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ben-Shalom</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Brozell</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Cerutti</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Cheatham</surname>, <given-names>T.</given-names></string-name>, &#x00026; <string-name><surname>Giambasu</surname>, <given-names>G.</given-names></string-name></person-group> (<year>2020</year>). Amber 2020.</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chiappetta</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Bottino</surname>, <given-names>V.</given-names></string-name>, &#x00026; <string-name><surname>Stier</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2020</year>). <article-title>COVID-19 and the role of chronic inflammation in patients with obesity</article-title>. <source><italic toggle="yes">International Journal of Obesity (2005)</italic></source>, <volume><italic toggle="yes">44</italic></volume>(<issue>8</issue>), <fpage>1790</fpage>&#x02013;<lpage>1793</lpage>. <pub-id pub-id-type="doi">10.1038/s41366-020-0597-4</pub-id><pub-id pub-id-type="pmid">32409680</pub-id></mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ebada</surname>, <given-names>S. S.</given-names></string-name>, <string-name><surname>Al-Jawabri</surname>, <given-names>N. A.</given-names></string-name>, <string-name><surname>Youssef</surname>, <given-names>F. S.</given-names></string-name>, <string-name><surname>Albohy</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Aldalaien</surname>, <given-names>S. M.</given-names></string-name>, <string-name><surname>Disi</surname>, <given-names>A. M.</given-names></string-name>, &#x00026; <string-name><surname>Proksch</surname>, <given-names>P.</given-names></string-name></person-group> (<year>2020</year>). <article-title>In vivo antiulcer activity, phytochemical exploration, and molecular modelling of the polyphenolic-rich fraction of Crepis sancta extract</article-title>. <source><italic toggle="yes">Inflammopharmacology</italic></source>, <volume><italic toggle="yes">28</italic></volume>(<issue>1</issue>), <fpage>321</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1007/s10787-019-00637-x</pub-id><pub-id pub-id-type="pmid">31482260</pub-id></mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eklund</surname>, <given-names>P. C.</given-names></string-name>, <string-name><surname>Backman</surname>, <given-names>M. J.</given-names></string-name>, <string-name><surname>Kronberg</surname>, <given-names>L. &#x000c5;.</given-names></string-name>, <string-name><surname>Smeds</surname>, <given-names>A. I.</given-names></string-name>, &#x00026; <string-name><surname>Sj&#x000f6;holm</surname>, <given-names>R. E.</given-names></string-name></person-group> (<year>2008</year>). <article-title>Identification of lignans by liquid chromatography-electrospray ionization ion-trap mass spectrometry</article-title>. <source><italic toggle="yes">Journal of Mass Spectrometry: JMS</italic></source>, <volume><italic toggle="yes">43</italic></volume>(<issue>1</issue>), <fpage>97</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1002/jms.1276</pub-id><pub-id pub-id-type="pmid">17729382</pub-id></mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="web"><person-group person-group-type="author"><string-name><surname>El-Hawary</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hammouda</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Tawfik</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Kassem</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Abdelshafeek</surname>, <given-names>K.</given-names></string-name>, &#x00026; <string-name><surname>El-Shamy</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2017</year>). Investigation of some chemical constituents, cytotoxicity and antioxidant activities of Beta Vulgaris var. altissima cultivated in Egypt. <italic>Rasayan Journal of Chemistry</italic>, <italic>10</italic>(4), 1391-1401. <pub-id pub-id-type="doi">10.7324/RJC.2017.1041936</pub-id></mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elshamy</surname>, <given-names>A. I.</given-names></string-name>, <string-name><surname>Ammar</surname>, <given-names>N. M.</given-names></string-name>, <string-name><surname>Hassan</surname>, <given-names>H. A.</given-names></string-name>, <string-name><surname>Al-Rowaily</surname>, <given-names>S. L.</given-names></string-name>, <string-name><surname>Ragab</surname>, <given-names>T. I.</given-names></string-name>, <string-name><surname>El Gendy</surname>, <given-names>A. E.-N G.</given-names></string-name>, &#x00026; <string-name><surname>Abd-ElGawad</surname>, <given-names>A. M.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Essential oil and its nanoemulsion of Araucaria heterophylla resin: Chemical characterization, anti-inflammatory, and antipyretic activities</article-title>. <source><italic toggle="yes">Industrial Crops and Products</italic></source>, <volume><italic toggle="yes">148</italic></volume>, <fpage>112272</fpage>
<pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112272</pub-id></mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Essmann</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Perera</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Berkowitz</surname>, <given-names>M. L.</given-names></string-name>, <string-name><surname>Darden</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.</given-names></string-name>, &#x00026; <string-name><surname>Pedersen</surname>, <given-names>L. G.</given-names></string-name></person-group> (<year>1995</year>). <article-title>A smooth particle mesh Ewald method</article-title>. <source><italic toggle="yes">The Journal of Chemical Physics</italic></source>, <volume><italic toggle="yes">103</italic></volume>(<issue>19</issue>), <fpage>8577</fpage>&#x02013;<lpage>8593</lpage>. <pub-id pub-id-type="doi">10.1063/1.470117</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fang</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Prior</surname>, <given-names>R. L.</given-names></string-name></person-group> (<year>2002</year>). <article-title>LC/MS/MS characterization of phenolic constituents in dried plums</article-title>. <source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source>, <volume><italic toggle="yes">50</italic></volume>(<issue>12</issue>), <fpage>3579</fpage>&#x02013;<lpage>3585</lpage>. <pub-id pub-id-type="doi">10.1021/jf0201327</pub-id><pub-id pub-id-type="pmid">12033832</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Genheden</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Ryde</surname>, <given-names>U.</given-names></string-name></person-group> (<year>2015</year>). <article-title>The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities</article-title>. <source><italic toggle="yes">Expert Opinion on Drug Discovery</italic></source>, <volume><italic toggle="yes">10</italic></volume>(<issue>5</issue>), <fpage>449</fpage>&#x02013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1517/17460441.2015.1032936</pub-id><pub-id pub-id-type="pmid">25835573</pub-id></mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ik</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Fleischer</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Annan</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Dickson</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Mensah</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Sarpong</surname>, <given-names>F.</given-names></string-name></person-group> (<year>2013</year>). <article-title>Anti-inflammatory, antioxidant and antimicrobial activity of the stem bark extract and fractions of Ficus exasperata Vahl.(Moraceae)</article-title>. <source><italic toggle="yes">Journal of Pharmacognosy and Phytochemistry</italic></source>, <volume><italic toggle="yes">2</italic></volume>(<issue>3</issue>), <fpage>38</fpage>&#x02013;<lpage>44</lpage>.</mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jayawardena</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Sooriyaarachchi</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Chourdakis</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Jeewandara</surname>, <given-names>C.</given-names></string-name>, &#x00026; <string-name><surname>Ranasinghe</surname>, <given-names>P.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Enhancing immunity in viral infections, with special emphasis on COVID-19: A review</article-title>. <source><italic toggle="yes">Diabetes &#x00026; Metabolic Syndrome: Clinical Research &#x00026; Reviews</italic></source>, <volume><italic toggle="yes">14</italic></volume>(<issue>4</issue>), <fpage>367</fpage>&#x02013;<lpage>382</lpage>.</mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="web"><person-group person-group-type="author"><string-name><surname>Jin</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Deng</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>Y.</given-names></string-name>, &#x00026; <string-name><surname>Duan</surname>, <given-names>Y.</given-names></string-name></person-group> (<year>2020</year>). Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19. <italic>BioRxiv</italic>
<pub-id pub-id-type="doi">10.1101/2020.02.26.964882</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jorgensen</surname>, <given-names>W. L.</given-names></string-name>, <string-name><surname>Chandrasekhar</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Madura</surname>, <given-names>J. D.</given-names></string-name>, <string-name><surname>Impey</surname>, <given-names>R. W.</given-names></string-name>, &#x00026; <string-name><surname>Klein</surname>, <given-names>M. L.</given-names></string-name></person-group> (<year>1983</year>). <article-title>Comparison of simple potential functions for simulating liquid water</article-title>. <source><italic toggle="yes">The Journal of Chemical Physics</italic></source>, <volume><italic toggle="yes">79</italic></volume>(<issue>2</issue>), <fpage>926</fpage>&#x02013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1063/1.445869</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kumarasamy</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Byres</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cox</surname>, <given-names>P. J.</given-names></string-name>, <string-name><surname>Jaspars</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Nahar</surname>, <given-names>L.</given-names></string-name>, &#x00026; <string-name><surname>Sarker</surname>, <given-names>S. D.</given-names></string-name></person-group> (<year>2007</year>). <article-title>Screening seeds of some Scottish plants for free radical scavenging activity</article-title>. <source><italic toggle="yes">Phytotherapy Research: PTR</italic></source>, <volume><italic toggle="yes">21</italic></volume>(<issue>7</issue>), <fpage>615</fpage>&#x02013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.2129</pub-id><pub-id pub-id-type="pmid">17357975</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Moon</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>H.-J.</given-names></string-name>, <string-name><surname>Park</surname>, <given-names>H. B.</given-names></string-name>, &#x00026; <string-name><surname>Kim</surname>, <given-names>K. H.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Bioactivity-guided isolation of anti-inflammatory triterpenoids from the sclerotia of Poria cocos using LPS-stimulated Raw264.7 cells</article-title>. <source><italic toggle="yes">Bioorganic Chemistry</italic></source>, <volume><italic toggle="yes">70</italic></volume>, <fpage>94</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2016.11.012</pub-id><pub-id pub-id-type="pmid">27912907</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mahmudpour</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Roozbeh</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Keshavarz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Farrokhi</surname>, <given-names>S.</given-names></string-name>, &#x00026; <string-name><surname>Nabipour</surname>, <given-names>I.</given-names></string-name></person-group> (<year>2020</year>). <article-title>COVID-19 cytokine storm: The anger of inflammation</article-title>. <source><italic toggle="yes">Cytokine</italic></source>, <volume><italic toggle="yes">133</italic></volume>, <fpage>155151</fpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2020.155151</pub-id><pub-id pub-id-type="pmid">32544563</pub-id></mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mart&#x000ed;nez-S&#x000e1;nchez</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Schwartz</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Donna</surname>, <given-names>V. D.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19</article-title>. <source><italic toggle="yes">Antioxidants</italic></source>, <volume><italic toggle="yes">9</italic></volume>(<issue>5</issue>), <fpage>389</fpage>
<pub-id pub-id-type="doi">10.3390/antiox9050389</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moawad</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hetta</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zjawiony</surname>, <given-names>J. K.</given-names></string-name>, <string-name><surname>Jacob</surname>, <given-names>M. R.</given-names></string-name>, <string-name><surname>Hifnawy</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Marais</surname>, <given-names>J. P.</given-names></string-name>, &#x00026; <string-name><surname>Ferreira</surname>, <given-names>D.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Phytochemical investigation of Cycas circinalis and Cycas revoluta leaflets: Moderately active antibacterial biflavonoids</article-title>. <source><italic toggle="yes">Planta Medica</italic></source>, <volume><italic toggle="yes">76</italic></volume>(<issue>8</issue>), <fpage>796</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1240743</pub-id><pub-id pub-id-type="pmid">20072955</pub-id></mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pillaiyar</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Manickam</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Namasivayam</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Hayashi</surname>, <given-names>Y.</given-names></string-name>, &#x00026; <string-name><surname>Jung</surname>, <given-names>S.-H.</given-names></string-name></person-group> (<year>2016</year>). <article-title>An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy</article-title>. <source><italic toggle="yes">Journal of Medicinal Chemistry</italic></source>, <volume><italic toggle="yes">59</italic></volume>(<issue>14</issue>), <fpage>6595</fpage>&#x02013;<lpage>6628</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01461</pub-id><pub-id pub-id-type="pmid">26878082</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pradelles</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Grassi</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Maclouf</surname>, <given-names>J.</given-names></string-name></person-group> (<year>1985</year>). <article-title>Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay</article-title>. <source><italic toggle="yes">Analytical Chemistry</italic></source>, <volume><italic toggle="yes">57</italic></volume>(<issue>7</issue>), <fpage>1170</fpage>&#x02013;<lpage>1173</lpage>. <pub-id pub-id-type="doi">10.1021/ac00284a003</pub-id><pub-id pub-id-type="pmid">3898913</pub-id></mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Purev</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Posp&#x000ed;&#x00161;il</surname>, <given-names>F.</given-names></string-name>, &#x00026; <string-name><surname>Motl</surname>, <given-names>O.</given-names></string-name></person-group> (<year>1988</year>). <article-title>Flavonoids from Ephedra sinica stapf</article-title>. <source><italic toggle="yes">Collection of Czechoslovak Chemical Communications</italic></source>, <volume><italic toggle="yes">53</italic></volume>(<issue>12</issue>), <fpage>3193</fpage>&#x02013;<lpage>3196</lpage>. <pub-id pub-id-type="doi">10.1135/cccc19883193</pub-id></mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rimon</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Sidhu</surname>, <given-names>R. S.</given-names></string-name>, <string-name><surname>Lauver</surname>, <given-names>D. A.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>J. Y.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>N. P.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Frieler</surname>, <given-names>R. A.</given-names></string-name>, <string-name><surname>Trievel</surname>, <given-names>R. C.</given-names></string-name>, <string-name><surname>Lucchesi</surname>, <given-names>B. R.</given-names></string-name>, &#x00026; <string-name><surname>Smith</surname>, <given-names>W. L.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1</article-title>. <source><italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic></source>, <volume><italic toggle="yes">107</italic></volume>(<issue>1</issue>), <fpage>28</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909765106</pub-id><pub-id pub-id-type="pmid">19955429</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ryckaert</surname>, <given-names>J.</given-names></string-name></person-group> (<year>1977</year>). <article-title>Ciccotti+, G. &#x00026; Berendsen, HJC numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of N-alkanes</article-title>. <source><italic toggle="yes">Journal of Computational Physics</italic></source>, <volume><italic toggle="yes">23</italic></volume>, <fpage>321</fpage>&#x02013;<lpage>341</lpage>.</mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>S&#x000e1;nchez&#x02010;Rabaneda</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Jauregui</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Lamuela&#x02010;Ravent&#x000f3;s</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Viladomat</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bastida</surname>, <given-names>J.</given-names></string-name>, &#x00026; <string-name><surname>Codina</surname>, <given-names>C.</given-names></string-name></person-group> (<year>2004</year>). <article-title>Qualitative analysis of phenolic compounds in apple pomace using liquid chromatography coupled to mass spectrometry in tandem mode</article-title>. <source><italic toggle="yes">Rapid Communications in Mass Spectrometry: RCM</italic></source>, <volume><italic toggle="yes">18</italic></volume>(<issue>5</issue>), <fpage>553</fpage>&#x02013;<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1002/rcm.1370</pub-id><pub-id pub-id-type="pmid">14978800</pub-id></mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schett</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Manger</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Simon</surname>, <given-names>D.</given-names></string-name>, &#x00026; <string-name><surname>Caporali</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2020</year>). <article-title>COVID-19 revisiting inflammatory pathways of arthritis</article-title>. <source><italic toggle="yes">Nature Reviews. Rheumatology</italic></source>, <volume><italic toggle="yes">16</italic></volume>(<issue>8</issue>), <fpage>465</fpage>&#x02013;<lpage>466</lpage>. <pub-id pub-id-type="doi">10.1038/s41584-020-0451-z</pub-id><pub-id pub-id-type="pmid">32561873</pub-id></mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Schrodinger</surname>, <given-names>L.</given-names></string-name></person-group> (<year>2010</year>). The PyMOL molecular graphics system, Version 1.3r1, vol. 5.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sobeh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mahmoud</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sabry</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Adel</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Dmirieh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>El-Shazly</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Wink</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2017</year>). <article-title>HPLC-PDA-MS/MS characterization of bioactive secondary metabolites from Turraea fischeri bark extract and its antioxidant and hepatoprotective activities in vivo</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume><italic toggle="yes">22</italic></volume>(<issue>12</issue>), <fpage>2089</fpage>
<pub-id pub-id-type="doi">10.3390/molecules22122089</pub-id></mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takao</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kitatani</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Watanabe</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Yagi</surname>, <given-names>A.</given-names></string-name>, &#x00026; <string-name><surname>Sakata</surname>, <given-names>K.</given-names></string-name></person-group> (<year>1994</year>). <article-title>A simple screening method for antioxidants and isolation of several antioxidants produced by marine bacteria from fish and shellfish</article-title>. <source><italic toggle="yes">Bioscience, Biotechnology, and Biochemistry</italic></source>, <volume><italic toggle="yes">58</italic></volume>(<issue>10</issue>), <fpage>1780</fpage>&#x02013;<lpage>1783</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.58.1780</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Trott</surname>, <given-names>O.</given-names></string-name>, &#x00026; <string-name><surname>Olson</surname>, <given-names>A. J.</given-names></string-name></person-group> (<year>2010</year>). <article-title>AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source><italic toggle="yes">Journal of Computational Chemistry</italic></source>, <volume><italic toggle="yes">31</italic></volume>(<issue>2</issue>), <fpage>455</fpage>&#x02013;<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id><pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Wolf</surname>, <given-names>R. M.</given-names></string-name>, <string-name><surname>Caldwell</surname>, <given-names>J. W.</given-names></string-name>, <string-name><surname>Kollman</surname>, <given-names>P. A.</given-names></string-name>, &#x00026; <string-name><surname>Case</surname>, <given-names>D. A.</given-names></string-name></person-group> (<year>2004</year>). <article-title>Development and testing of a general amber force field</article-title>. <source><italic toggle="yes">Journal of Computational Chemistry</italic></source>, <volume><italic toggle="yes">25</italic></volume>(<issue>9</issue>), <fpage>1157</fpage>&#x02013;<lpage>1174</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20035</pub-id><pub-id pub-id-type="pmid">15116359</pub-id></mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organiztion</collab></person-group> (<year>2020</year>). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients">https://www.who.int/news-room/detail/16-06-2020-who-welcomes-preliminary-results-about-dexamethasone-use-in-treating-critically-ill-covid-19-patients</ext-link>.</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yao</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ou</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>P.</given-names></string-name>, &#x00026; <string-name><surname>Lin</surname>, <given-names>X.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Analysis of the total biflavonoids extract from Selaginella doederleinii by HPLC-QTOF-MS and its in vitro and in vivo anticancer effects</article-title>. <source><italic toggle="yes">Molecules</italic></source>, <volume><italic toggle="yes">22</italic></volume>(<issue>2</issue>), <fpage>325</fpage>
<pub-id pub-id-type="doi">10.3390/molecules22020325</pub-id></mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zabetakis</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Lordan</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Norton</surname>, <given-names>C.</given-names></string-name>, &#x00026; <string-name><surname>Tsoupras</surname>, <given-names>A.</given-names></string-name></person-group> (<year>2020</year>). <article-title>COVID-19: The inflammation link and the role of nutrition in potential mitigation</article-title>. <source><italic toggle="yes">Nutrients</italic></source>, <volume><italic toggle="yes">12</italic></volume>(<issue>5</issue>), <fpage>1466</fpage>
<pub-id pub-id-type="doi">10.3390/nu12051466</pub-id></mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sun</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Curth</surname>, <given-names>U.</given-names></string-name>, <string-name><surname>Drosten</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Sauerhering</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Becker</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rox</surname>, <given-names>K.</given-names></string-name>, &#x00026; <string-name><surname>Hilgenfeld</surname>, <given-names>R.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x003b1;-ketoamide inhibitors</article-title>. <source><italic toggle="yes">Science (New York, N.Y.)</italic></source>, <volume><italic toggle="yes">368</italic></volume>(<issue>6489</issue>), <fpage>409</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb3405</pub-id></mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meng</surname>, <given-names>X.-Y.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>X.-H.</given-names></string-name>, <string-name><surname>Mezei</surname>, <given-names>M.</given-names></string-name>, &#x00026; <string-name><surname>Cui</surname>, <given-names>M.</given-names></string-name></person-group> (<year>2011</year>). <article-title>Molecular docking: A powerful approach for structure-based drug discovery</article-title>. <source><italic toggle="yes">Current Computer-Aided Drug Design</italic></source>, <volume><italic toggle="yes">7</italic></volume>(<issue>2</issue>), <fpage>146</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.2174/157340911795677602</pub-id><pub-id pub-id-type="pmid">21534921</pub-id></mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salmaso</surname>, <given-names>V.</given-names></string-name>, &#x00026; <string-name><surname>Moro</surname>, <given-names>S.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview</article-title>. <source><italic toggle="yes">Frontiers in Pharmacology</italic></source>, <volume><italic toggle="yes">9</italic></volume>, <fpage>923</fpage>
<pub-id pub-id-type="doi">10.3389/fphar.2018.00923</pub-id><pub-id pub-id-type="pmid">30186166</pub-id></mixed-citation></ref></ref-list></back></article>